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Human embryonic stem cells (hESCs) possess unique properties in terms of self-
renewal and differentiation, which make them particularly well-suited for use in 
tissue engineering and regenerative medicine.  The differentiation of hESCs in the 
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form of human embryoid bodies (hEBs) recapitulates early embryonic development, 
and hEBs may provide useful insight into the embryological development of humans. 
Herein, cell-penetrating magnetic nanoparticles (MNPs) were utilized to form 
hEBs with defined sizes and the differentiation patterns were analyzed.  The MNPs 
were sufficiently delivered into hESCs, when feeder-free culture system of the 
hESCs was applied.  Then the suspended and magnetized hESCs efficiently 
clustered into hEBs driven by magnetic pin-based concentrated magnetic force 
system.  The size of hEBs was controlled by varying the suspended cell numbers 
which were added in a well of the concentrated magnetic force system.  After 3 
days of differentiation in a suspended condition, ectodermal differentiation was 
enhanced in small hEBs (150 μm in diameter) while endodermal and mesodermal 
differentiation was enhanced in large hEBs (600 μm in diameter). 
In the spontaneous differentiation of size-controlled hEBs, some of small-sized 
hEBs, which showed glial fibrillary acidic protein (GFAP)-positive staining, 
sprouted neurite-like outgrowth.  In fact, many researchers have tried to induce 
neural differentiation of the hEBs due to the similarity of tissue elasticity to the 
brains and the correspondence of the enhanced intercellular interactions with the 
actual nerve cells.  In this work, to improve the neural development of small-sized 
hEBs, neural induction medium (NIM) was applied for 5 days (Ⅳ) and they were 
compared with 3 other groups of hESCs; the undifferentiated hESCs which 
maintained their pluripotency (Ⅰ), the hESCs neurally induced in NIM for 5 days (Ⅱ) 
and the hESCs neurally induced in NIM with the MNPs for 5 days (Ⅲ).  Neurally 
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induced small hEBs showed significantly improved neural induction compared to 
the other groups.  Furthermore, the MNPs themselves demonstrated neurogenic 
effect synergic with NIM.  Additionally, signaling pathways of the accelerated 
neural induction of Ⅳ were detected through expression of representative proteins; 
WNT proteins, dopaminergic neuronal proteins, proteins related to intercellular 
communications, and proteins related mechanotransduction. 
To summarize, MNP-based size-controlled hEB generation method was devised 
and using this technique, it was revealed that the size of hEBs is one of the important 
factors that determine the direction of early differentiation of hESCs.  In addition, 
small-sized hEBs, generated via the MNP-based methodology, were neurally 
induced and the neural induction was effectively improved, reducing the time 
required for early neural induction.  Furthermore, it was confirmed that this process 
followed the WNT3 signaling pathways and dopaminergic neuronal pathways.  
Additionally, it was revealed that this result was caused by the enhancement of the 
intercellular interactions and mechanotransduction, resulting from the hEB 
generation technique using MNPs.  Therefore, the MNP-based hEB size control 
method proposed in this study would be useful for inducing lineage-specific 
differentiation of hESCs and determining the cell fate.  If this technology could be 
used to induce the differentiation of hESCs into a variety of cell types, applications 
to tissue engineering and simulations of embryogenesis would be possible. 
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Chapter 1. Research background and objectives 
Since the discovery of their existence, stem cells have been consistently 
considered as a hope for the treatment of incurable diseases due to the self-renewal 
ability and pluripotency [1, 2], which are inherent characteristics of the stem cells 
[3-5].  In particular, human embryonic stem cells (hESCs) isolated from human 
embryos (in detail, inner cell mass of the blastocysts) have the potential to become 
almost all cell types in our body [6, 7].  Therefore, efforts have been made to induce 
differentiation of the hESCs into specific cells, which are difficult to recover and 
regenerate once damaged, represented as neurons and cardiomyocytes [8, 9]. 
Researchers have tried to make efficient use of these potentials of the stem cells, 
that is to say, the differentiation of stem cells into specific cells was never easy [10-
12].  Although embryogenesis of in vivo embryos has completely differentiated 
stem cells into various cells, there have been limitations to differentiate the hESCs 
in vitro [13, 14].  In order to induce the differentiation of stem cells into specific 
cells, it is difficult to achieve homogeneous differentiation in which all cells undergo 
the same differentiation [15, 16], even if the hESCs are treated with chemical 
inducers [17-20].  To control the hESCs differentiating into different types under 
the same conditions, the researchers became interested in the physical environment 
applied to the stem cells [21-23]. 
The approach to the physical environments of the hESCs began with mimicking 
actual hESCs, to emulate the in vivo condition in which embryos are cultured [15, 
24-27].  Therefore, there have been various attempts to aggregate the hESCs to 
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produce three-dimensional (3D) form of the hESCs, called hEBs [28, 29]. 
In this study, through hEB generation with a novel and efficient method, the fate 
of the hESCs was regulated by differentiating them into specific lineages, and to 
improve the directing efficiency.  In order to produce hEBs, nanotechnology of 
magnetic nanoparticles (MNPs) was utilized because this method was considered as 
a solution to overcome the limitations of the conventional cell assembling; non-
uniformity of cell aggregates and different sizes [30-34].  The uniform and size-
controlled hEB generation was required to investigate whether the differentiation 
direction differs according to the diameter of hEBs, furthermore, whether this initial 
direction of differentiation could improve the neural induction of the hESCs. 
If the fate of hESCs in early stage can be regulated and thus the efficiency of 
lineage-specific differentiation could be enhanced, this technology would be 
applicable not only to treat the degenerative diseases, but also to understand the 
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Chapter 2. Literature review 
2.1 Stem cell 
2.1.1 Embryonic stem cell (ESC) and adult stem cell 
Stem cells have the potential to be distinguished from many other mammalian 
cells which are already given their own functions and are already performing well 
[35, 36].  A stem cell has its own ability to transform into various cell types that 
constitute a specific tissue or organ in the body [6, 7].  These stem cells are 
classified into two types depending on the collection timing (Figure 2.1.1.1) [37].  
If the donor decides to provide cells before birth, the stem cells extracted from the 
inner cell mass of embryo at the blastocystic stage are called “embryonic stem cells 
(ESCs)”.  Otherwise, when the donor decides to provide cells after birth, the stem 
cells extracted from the adult are called “adult stem cells”.  Since the characteristics 
of adult stem cells differ depending on the actual extraction location of the body, 
usually origin comes along; fat-derived, bone marrow-derived and etc [38-40]. 
Stem cells differ in their ability to change, depending on their type.  As ESCs are 
extracted from the developmental stage of embryos, they can be transformed into 
almost all kinds of cells that make up our body, and this ability is called “pluripotency” 
[37].  Since adult stem cells have already been separated in a particular lineage, 
there are several possibilities for divergence, called “multipotency” [38-40].  
Regardless of their degrees of the potentials, researchers have tried to utilize the stem 












because of the advantages that stem cells can be transformed into various cells.  It 
would be possible to transform stem cells into specific cells of damaged tissue in the 
body in order to use them in therapy by reconstructing damaged organs and also in 
order to generate a model that mimics the body in vitro [41, 42]. 
However, for these studies, the transformation of stem cells needs to be controlled 
precisely.  This transformation is called “differentiation”, and research using stem 
cells focuses on narrowing and limiting the direction of this differentiation, and 
increasing its efficiency [15, 16].  If the differentiation of stem cells cannot be 
precisely controlled, there may be a mixture of unintended cell types, as well as the 
cells of a specific tissue intended by the researcher.  The result of this 
heterogeneous differentiation is a direct cause of tumor formation and also is a major 
obstacle in clinical research using stem cells.  Therefore, in order to take full 
advantage of the attractive properties of the stem cells, it is important to develop 
chemical and physical methods that homogeneously differentiate the stem cells into 




2.1.2 Regulation of stem cell differentiation 
In studies using stem cells, researchers have tried to differentiate stem cells into 
specific cell types suitable for application to particular tissues [7, 10-13].  In this 
process, elaborate regulation is required for the cell differentiation into homogeneous 
cell types.  However, the methods of precise differentiation control should be 
improved to achieve high efficiency on homogeneous performance.  Although the 
details of the mechanisms involved in stem cell differentiation have not been fully 
elucidated, there have been considerable progresses in research on chemical factors 
that influence the direction of differentiation.  Thus, the chemical factors, 
represented as particular growth factors and cytokines that induce designated 
signaling pathways through chemical cues, have widely been used commercially for 
controlled differentiation of stem cells into targeted tissue-specific cells. 
Recently, there is an academic interest in the physical factors that act as regulators 
of stem cell differentiation [43, 44].  Determination of cell fate based on various 
methods and degree of physical stimuli, which stem cells perceive from extracellular 
environment, is important for researchers studying the direction of stem cell 
differentiation. 
Physical factors transmit specific signals to stem cells through mechanical 
stimulations [45].  When a physical factor-recognizing receptor on the surface of a 
cell receives stimulation, intracellular cytoskeletons connected to the receptor are 
stimulated sequentially [46, 47].  This is initially a physical force, such as simple 
pull or push, but it is converted into a signal that causes a conformational change of 
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particular downstream proteins.  Then, it affects the expression of specific genes in 
the nucleus of a cell, resulting in regulation of stem cell differentiation.  Thus, 
physical factor-based control of stem cell fate is capable via cell-level perception of 
external physical stimuli and then cytoskeleton-derived particular cascades.  
Therefore, in order to differentiate stem cells in a desired direction, it is important to 
precisely control the physical stimulations and the microenvironments of stem cells. 
 
2.1.3 Stem cell in three-dimension (3D) 
To achieve regulated differentiation of ESCs, there have been attempts to make 
the cells in the form of 3D mimicking the embryos [48].  Comparing with two-
dimensional (2D) ESC cultivation and differentiation method, which is still 
conventionally used in laboratory, 3D embryoid body (EB) generation and 
differentiation method has been proposed as an ideal method for efficient 
differentiation of the ESCs [24-29].  Since the EBs are modeled on the morphology 
of embryos, ESCs in the form of EBs are spontaneously induced to differentiate into 
a variety of directions. 
Researchers have tried to generate EBs through various cell clustering methods 
including the hanging-drop method, which has been widely used for a long time, 
non-sticking surface culture method, and porous 3D scaffold culture method (Figure 













limitations in producing cell aggregates of uniform size, and thus it may be difficult 
to use these methods for exquisite ESC differentiation.  Recently, microscale 
technology has been applied to EB production to overcome this problem (Figure 
2.1.3.2) [34, 52-57].  Microfluidic devices [52-54] and microwells [55-57] were 
used as elaborate methods for EB generation of uniform diameter.  However, the 
EB fabrication method using the microscale technique still has limitations on the 
efficiency of the platform fabrication, the time required for the final EB generation, 














2.2 Magnetic nanoparticles (MNPs) 
2.2.1 Characteristics of MNPs 
There are many kinds of magnetic particles used in biochemistry.  Properties 
such as size, magnetism and surface are controlled according to biochemical uses 
[58-62].  Most of the magnetic particles are applied for the mechanotransduction of 
cells since they are mostly sized to nanoscale in order to enable intracellular delivery 
and accumulation [62-67].  Those nano-sized magnetic particles, called “magnetic 
nanoparticles (MNPs)” that are incorporated in cells, physically stimulate the 
intracellular organelles, resulting in determination of the cell fate [68].  Magnetic 
properties of the MNPs are usually dependent on their size, thus they possess various 
properties ranging from superparamagnetism to ferromagnetism, according to their 
size [69-74].  This property is important in the interaction with an extracellular 
magnetic field, which would be artificially provided for controlling the 
differentiation of cells, based on magnetic force [75-83].  The MNPs are produced 
by chemical or biological synthesis.  Chemical synthesis of the MNPs is a common 
method of manufacturing to ensure uniformity of dimensions and various surface 
coatings [58-60].  Meanwhile, biological synthesis of the MNPs from magnetic 
bacteria solves the problem of biocompatibility [23, 84]. 
Among the various biological usages, application of the MNPs for stem cell 
research and tissue engineering has been popularized [85].  This is because MNP-
based activation has proven to be effective for controlling stem cell differentiation 
efficiency [75-83].  In this research field, the MNPs commonly used possess iron 
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oxide as a core due to the convenience in coprecipitation of iron salt and also in 
surface modification with various functional materials [58-61]. 
When the synthesized MNPs are applied to stem cells, they can attach to the cell 
surface via receptor-ligand binding, or can incorporate into the cells through 
endocytosis [62-67].  MNPs bound to the cell surface physically influence the cell 
membranes, and thus intracellular organelles by the manipulation of magnetic field 
outside the cell [68].  This allows elaborate regulation of stem cell differentiation 
by inducing acute mechanotransduction processes.  And the MNPs incorporated 
into the cells contribute to magnetization of the cells [84, 86].  When a cell is 
magnetized, it acts like a small magnet, thus its movement can be controlled by 
external magnetic force.  Therefore, cell aggregates can be simply produced, and 
such methods can be applied to tissue engineering and regenerative medicine using 
stem cells. 
 
2.2.2 Benefits of using MNPs in biological applications 
2.2.2.1 Controllability of elaborate differentiation 
As discussed above, in the studies using stem cells, differentiation of stem cells 
into specific cells of a desired tissue has important significance in tissue engineering 
and regenerative medicine [35, 41, 87].  Thus, methods have been studied to control 
the fate of stem cells and, consequently, to increase the efficiency of homogenous 
differentiation into restricted cell types [42].  Various types of stimuli or factors 
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have been applied to the stem cells for the effective stem cell differentiation [88, 89].  
These factors may be chemical factors such as growth factors or physical factors, 
that provide mechanical stimulation.  Since physical factors can be managed finely 
and thus useful for investigating unknown mechanisms of chemical factors, 
researchers have paid attention to the physical cues [43, 44].  These physical factors 
could be applied to stem cells without any chemical factors, or in combination with 
some chemical factors for synergistic effects on stem cell differentiation [43, 44, 90]. 
In various types of physical stimuli, the effects of magnetic stimulation on the 
regulation of stem cell differentiation have been studied [45-47, 90].  Magnetic 
stimulation uses the MNPs and exterior magnetic force.  Since the magnitude of the 
magnetic force can be easily manipulated, it is possible to control the differentiation 
simply by applying magnetic force to MNP-incorporated stem cells [85].  Although 
the mechanisms causing the differentiation of stem cells have not been elucidated in 
detail, it is known that the differentiation is roughly based on the regulation of 
downstream protein expression in cytosols and the regulation of gene expression in 
nuclei [46, 47].  Because the MNPs are nanoscale in size, they can be applied to 
these downstream protein levels, which can lead to sensitive differentiation 
regulation through elaborate stimulation regulation. 
 
2.2.2.2 Efficient cell maintenance during transplantation 
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The ultimate goal of tissue engineering is to repair a damaged tissue or organ [3-
5].  Thus, stem cells that are differentiated into a specific cell types of the targeted 
tissue, are eventually injected into the body in order to replace the damaged tissue 
area [91, 92].  Therefore, successful engraftment of cells is crucial when such 
surgical implantation is required in clinical practice.  Due to the speed of the 
moving fluid (body fluids containing blood), most injected cells are scattered by the 
liquid before they provide a healing effect [93].  Thus, increasing the cell 
maintenance efficacy of damaged areas is an important limitation for successful 
transplantation. 
There have been many attempts to immobilize the cells to the desired area [94, 
95].  Because immobilization of cells depends on physical cues, a variety of 
physical forces are used to stably bind the cells in situ.  Among the various physical 
stimulation methods, the magnetic force-based cell maintenance method has gained 
popularity with its simplicity and effectiveness [93, 96, 97].  If the cells are 
magnetized by the incorporation of the MNPs, this method becomes simpler.  This 
is because the mobility of the injected magnetized cells can be sufficiently controlled 
by the external magnetic force.  Recently, studies on tissue engineering using MNP-
based cell maintenance method have shown that the grafted cells can be effectively 
immobilized at desired points by external magnetic forces [84, 86].  Therefore, 
strategies using MNPs and magnetic force can be applied not only to differentiation 




2.2.3 MNP-based stem cell fate commitments 
The application of physical force using the MNPs is advantageous for precise 
control of stem cell fate [88, 89].  Since the MNPs are magnetically managed, fine 
control of the cell commitments by delivering a physical effect into cells is possible 
through exquisite regulation of exterior magnetic force under MNPs-cells combined 
condition [62-67].  By modulating the magnetic force outside the cells, the MNPs 
bound to the cells can be clustered or dispersed to each other, and also can be pulled 
or rotated in a specific direction [66, 69, 83].  It may lead to morphological changes 
of the cells such as lengthening or twisting of the cellular structure, resulting in 
changes in the intracellular organelles, especially the cytoskeletons which ultimately 
affects the intracellular signaling pathways into the cells.  The physical stimuli 
delivered to the intracellular organelles is a significant factor that determines the 
phosphorylation of some downstream proteins, and through this, a specific cascade 
could be expressed or inhibited, which ultimately affects gene expression in the 
nuclei [98-106].  As a result, it is possible to derive such precise results through the 
technology of an external artificial magnetic field control and the MNP synthesis 
technique, by which the characteristics of MNPs such as size, magnetic force, and 
surface materials can be regulated. 
Alternatively, the MNPs can be incorporated into stem cells inducing the cells to 
behave like a small magnet for the regulation of cell fate [23, 62-67, 84, 86].  By 
the MNP introduction, the cells with MNPs are magnetized and those magnetized 
cells are responsive to external magnetic forces.  When a magnetized cell is 
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attached to a substrate and is subjected to a pulling force to specific direction by a 
static magnetic force, the cell may experience artificial pressure or tension [83].  On 
the other hand, free-floating magnetized cells may have mobility due to an external 
magnetic field to specific direction [66, 69, 83].  At this time, they may be exposed 
to a rotating stimulus by an external variable magnetic field, which causes shear 
stress to the cells in the fluid [23].  In such a process it is difficult to distinguish 
which of the complex interconnected factors specifically influence the regulation of 
cell fate commitments.  However, it is clear that the effects on the cells and thus the 








Experimental procedures  
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Chapter 3. Experimental procedure 
3.1 Cell culture 
3.1.1 Conventional culture of human embryonic stem cells 
(hESCs) 
Human embryonic stem cells (hESCs, SNUhES31) were donated at passage 23 
from the Seoul National University Medical Research Center after obtaining 
approval from the Seoul National University Institutional Review Board (IRB 
No.1402/002-006).  Human ESCs were maintained in a pluripotent state under the 
standard hESC growth condition following previously described protocols [10, 16, 
107].  Briefly, the hESCs were grown with mitotically inactivated STO mouse 
fibroblast cells (STO) on 0.2% gelatin-coated tissue culture dishes in Dulbecco's 
Modified Eagle Medium: Nutrient Mixture F-12 (DMEM ⁄ F-12, Gibco, USA) 
supplemented with 20% KnockOut™ Serum Replacement (KOSR, Gibco, USA), 4 
ng/ml basic fibroblast growth factor (bFGF, Invitrogen, USA), 0.1 mM β-
mercaptoethanol (BME, Sigma, USA), 0.1 mM nonessential amino acids (NEAA, 
Gibco, USA) and 50 units/ml penicillin, and 50 μg/ml streptomycin (PS, Gibco, 
USA).  Five to seven days after the initial plating, the hESC colonies were 
mechanically dissociated by modified Pasteur pipettes and re-plated on a fresh feeder 
layer.  Human ESCs were culture at 37 °C in a humidified CO2 incubator and the 
medium for the hESCs with feeder was exchanged every single day. 
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STO was grown and prepared for use as feeder cells as described in previous 
studies [10, 107].  In brief, STO was treated with 5 μg/ml Mitomycin C (MMC, 
Sigma, USA) to inactivate the cell division, and then 2.5×105 cells were transferred 
onto a gelatinized 35 mm dish after detaching via 0.25% trypsin- 
ethylenediaminetetraacetic acid (EDTA) (TE, Sigma, USA) to feed the hESCs. 
 
3.1.2 Feeder-free culture of hESCs 
To minimize the STO contribution to generation of human embryoid bodies (hEBs) 
and differentiation of hESCs, a feeder-free system was applied.  Conventionally 
cultured hESCs were transferred mechanically to dishes coated with Geltrex™ 
(Gibco, USA) and they were cultured in Essential 8™ Medium (Gibco, USA) as 
described in prior studies, without any adverse effects on pluripotency [107].  The 
medium for the hESCs without feeder was exchanged every single day. 
 
3.1.3 Culture of human mesenchymal stem cells (hMSCs) 
Bone marrow-derived human mesenchymal stem cells (hMSCs) were purchased 
at passage 2 from Lonza (Switzerland).  hMSCs were maintained in 75 cm2 tissue 
culture flasks in mesenchymal stem cell growth medium (MSCGM™) 
supplemented with MSCGM™ SingleQuots™ Kit (Lonza, Switzerland) at 37 °C 
in a humidified CO2 incubator.  Cells were detached using 0.25% TE when they 
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have reached approximately 95% cellular confluence and re-seeded for transfer.  
Passage 3 to 5 cells were used for experiments. 
 
3.1.4 Culture of mouse embryonic stem cells (mESCs) 
Mouse embryonic stem cells (mESCs, R1) were maintained with feeder layers of 
MMC-treated mouse embryonic fibroblast (MEF) on gelatin-coated tissue culture 
dishes.  The culture medium for mESC was knockout-DMEM (KO-DMEM, Gibco, 
USA) supplemented with 15% fetal bovine serum (FBS, Gibco, USA), 103 units/ml 
of leukemia inhibitory factor (LIF, Chemicon, USA), 0.1 mM BME, 100 mM NEAA 
and 50 units/ml penicillin, and 50 μg/ml streptomycin in a humidified incubator with 




3.2 Preparation of magnetic nanoparticles (MNPs) 
3.2.1 Preparation of Magnetospirillum sp. AMB-1 
The magnetic bacterium, Magnetospirillum sp. AMB-1 (ATCC 700264) was 
purchased from ATCC and then cultured in magnetic spirillum growth medium 
(MSGM), revised according to Blakemore’s paper [86, 108].  One liter of the 
modified MSGM contained 10 ml of Wolfe’s vitamin solution, 5 ml of Wolfe’s 
mineral solution, 0.02 g of ferrous sulfate (Sigma, USA), 0.45 mL of 0.1% resazurin 
(Sigma, USA), 0.68 g of monopotassium phosphate (KH2PO4, Yakuri, Japan), 0.12 
g of sodium nitrate (NaNO3, Junsei, Japan), 0.035 g of ascorbic acid (Sigma, Japan), 
0.37 g of tartaric acid (Sigma, Japan), 0.37 g of succinic acid (Sigma, Japan) and 
0.05 g of sodium acetate (Sigma, Japan).  The pH of the medium was adjusted to 
6.75 with a 0.5 N sodium hydroxide (NaOH, Junsei, Japan) solution before 
sterilization. 
AMB-1 cells were anaerobically pre-cultured in 50 ml of a growth medium in a 
shaking incubator at 27 °C and 150 rpm overnight.  And then, the pre-cultured 
bacteria were inoculated into fermenter containing 3 ml of MSGM, after medium 
saturation with nitrogen gas for 30 min to provide anaerobic condition.  The 
bacteria were anaerobically fermented for 5 days at 27 °C with stirring and feeding.  
One liter of feeding solution contained 1 ml of distilled water supplemented with 50 
g of succinic acid, 80 g of sodium nitrate, 20 ml of nitric acid (HNO3, Junsei, Japan) 
and 1.5 g of ferrous sulfate.  When fermentation was finished, the color of 




3.2.2 Isolation and purification of MNPs 
Ferromagnetic nanoparticles (MNPs, Fe3O4) were gained from anaerobically 
fermented magnetotactic bacteria (Figure 3.2.2.1) [23, 84].  After the 5-day long 
fermentation, AMB-1 cells were gathered via 11,300×g centrifugation for 20 min.  
And then the bacterial cells were ruptured via sonication with 35% amplification for 
15 min (VCX500, Sonics & Materials, USA).  The MNPs were isolated from the 
total solution using neodymium-iron-boron (NdFeB) magnets.  The NdFeB 
magnets were attached beneath the Petri dishes, and the solution containing the 
MNPs was poured out on the magnet-installed Petri dishes.  Contrary to other 
debris, only the MNPs in the solution were stuck onto the areas of the magnets, and 
flowing solution was discarded by pipettes except for the MNPs anchored to the 
magnets.  After detaching the NdFeB magnets, the MNPs flowed down, and 
gathered.  The isolated MNPs were washed using phosphate buffered saline (PBS, 
Welgene, Korea), and the magnetic isolation following PBS washing was repeated 3 
times for purification.  The MNPs were sterilized using an autoclave as a dispersion 
in PBS.  After measuring the concentration using ICP-AES (ICPS-7500, Shimadzu, 
Japan), the MNPs were concentrated to 1 mg/ml in PBS and then stored at 4 °C.  
Just before application to the mammalian cells for experimental purpose, the MNPs 
were entirely dispersed using an ultrasonicator (JAC 1002, Kodo Technical Research, 













3.3 Spheroid generation using MNPs 
The hMSCs, mESCs and hESCs were respectively incubated with 20 μg/ml cell-
penetrating MNPs at 37 °C in a humidified CO2 incubator for 24 h.  The MNPs 
were incorporated into cells, resulting in magnetization of the cells.  Then the 
MNP-incorporated cells on dishes were detached from the plate with 0.25% TE or 
Accutase™ Solution (Millipore, USA).  The cells were suspended in a medium and 
then added into the concentrated magnetic force system, which was manufactured 
following the previous work [84].  In brief, the lids of 96-well plates were prepared 
with static magnets (10 mm×5 mm×2 mm) placed on the cover and iron pins attached 
to the magnets under the lids.  The 130 to 135 ml of cell suspension was added into 
each well at different cell number.  The magnetized cells were driven to move 
toward the iron pin, at which magnetic force was concentrated (450 mT), resulting 




3.4 Differentiation of stem cells 
3.4.1 Spontaneous differentiation of human embryoid bodies 
(hEBs) 
For spontaneous induction of early differentiation, the human embryoid bodies 
(hEBs) were cultured in suspended condition for 3 days at 37 °C in a humidified 
CO2 incubator in a hEB medium.  In a hEB medium, bFGF was excluded from 
standard hESC growth medium.  Therefore, the hEB medium was composed of 
DMEM ⁄ F-12, supplemented with 20% KOSR, 0.1 mM BME, 0.1 mM NEAA, 50 
units/ml penicillin, and 50 μg/ml streptomycin. 
 
3.4.2 Neural induction of hESCs and hEBs 
For neural induction, the hESCs were cultured in neural induction medium (NIM, 
Gibco, USA) for 5 days at 37 °C in a humidified CO2 incubator.  The medium was 
exchanged every 3 days.  Also, the hEBs were neurally induced via NIM in 




3.5 Cell viability test 
3.5.1 Cell counting kit-8 (CCK-8) assay 
To examine the cytotoxicity of the MNPs on hMSCs and hESCs respectively, Cell 
Counting Kit-8 (CCK-8, Dojindo, USA) was used following the manufacturer’s 
instruction.  In brief, after the incubation of the cells with MNPs for 24 h at 37 °C 
in a humidified CO2 incubator, CCK-8 solution was added at 10% concentration.  
The absorbance of each well was measured at 450 nm, following an additional 
incubation in the incubator for 2 h. 
 
3.5.2 Fluorescence-based live and dead assay 
In order to detect the live and dead hESCs in hEBs, LIVE/DEAD cell viability kit 
(Molecular Probes, USA) was used.  The hEBs were treated with a mixed solution 
of 2 μM acetoxymethyl ester of calcein (calcein AM) and 4 μM ethidium 
homodimer-1 (EthD-1).  After incubation for 1 h at 37 °C in a humidified CO2 





3.6 Intracellular uptake of MNPs 
3.6.1 Transmission electron microscopy (TEM) analysis 
The MNPs endocytosed in hMSCs and hESCs were observed via transmission 
electron microscopy (TEM), respectively.  After incubation with 20 μg/ml cell-
penetrating MNPs, the cells were fixed with paraformaldehyde-glutaraldehyde 
solution (Karnovsky's Fixative) for 2 h at 4 °C.  The cells were then washed with 
0.05 M sodium cacodylate buffer.  Subsequently, the cells were fixed with 2% 
osmium tetroxide with 0.1 M cacodylate buffer for 2 h and washed using distilled 
water, followed by overnight 0.5% uranyl acetate treatment for negative staining at 
4 °C.  After serial dehydration with sequentially concentrated ethanol from 30% to 
100%, the cells were treated with propylene oxide to remove the residual ethanol.  
Finally, they were penetrated by propylene oxide with resin mixture and then the 
cells were embedded in resin.  The embedded samples were cut using an 
ultramicrotome (EM UC7, Leica, Germany) and were then observed via TEM 
(JEM1010, JEOL, Japan). 
 
3.6.2 Prussian blue staining 
The endocytosed MNPs into hMSCs and hESCs were detected using a Prussian 
blue staining kit (Sigma, USA) according to the manufacturer’s instruction.  After 
washing the cells with PBS, they were fixed with 4% paraformaldehyde (PFA) for 5 
min at room temperature.  The cells were then washed with distilled water followed 
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by permeabilization using 0.25% Triton X-100 in phosphate buffer saline (PBST) 
for 10 min at room temperature.  After washing with distilled water, the cells were 
treated with 1:1 mixture of potassium ferrocyanide and hydrochloric acid for 10 min 
at room temperature.  Then, the cells were washed with distilled water and were 
counterstained with 2% pararosaniline solution for 5 min at room temperature.  
After washing with distilled water and drying, the cells incorporated with MNPs 




3.7 Real time reverse transcription-polymerase chain reaction 
(RT-PCR) 
To analyze differentiation of the hESCs and hEBs, the expression of related 
mRNA was measured through reverse transcription-polymerase chain reaction (RT-
PCR) method.  In order to detect early differentiation of small and large hEBs, the 
relative expression of gastrulational genes specifying the ectoderm, endoderm and 
mesoderm was measured.  And to identify degree of neural induction of hESCs and 
hEBs, the relative expression of neural genes was detected. 
 The total RNA was extracted using TRIzol® RNA Isolation Reagents (Invitrogen, 
USA) according to the manufacturer’s instructions.  After cell gathering by 
centrifugation, cells were lysed by TRIzol solution and they were incubated at room 
temperature for 5 min for nuclear complex dissociation.  Chloroform (Millipore, 
Germany) was added at 20% concentration and total solution was shook 15 sec, then 
subsequently incubated at room temperature for 2 to 3 min.  After 12,000×g 
centrifugation for 15 min at 4 °C, the solution was separated into 3 phases and the 
colorless upper aqueous phase was transferred to fresh tube.  Then, isopropyl 
alcohol (2-propanol, Millipore, Germany) was added to the transferred supernatant 
at 1:1 volume and they were centrifuged at 12,000×g for 10 min at 4 °C for RNA 
precipitation.  After centrifugation, supernatant was discarded and then RNA was 
washed by vortex with 75% ethanol (Millipore, Germany).  After centrifugation of 
the solution at 7,500×g for 5 min at 4 °C and the supernatant removal, RNA pellet 
was dried for 1 h at room temperature and resolved in RNase free water (iNtRON 
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Biotechnology, South Korea), subsequently incubated at 55 to 60 °C for 10 min. 
Reverse transcription was then carried out using 500 ng of total RNA with each 
reaction of a M-MLV cDNA synthesis kit (Enzynomics, South Korea), following the 
manufacturer’s instructions.  Real-time RT-PCR was performed with TOPreal™ 
qPCR 2X PreMIX (Enzynomics, South Korea), utilizing a StepOnePlus™ Real-
Time PCR System (Applied Biosystems, USA). 
Each of the expressed genes was normalized by glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH), an endogenous reference gene, and were then analyzed 
using relative quantification methods.  The pluripotency of the hESCs and hEBs 
was determined respectively by detecting octamer-binding transcription factor 4 
(OCT4) expression.  The relative expression values were represented as the fold 
changes in the gene expression relative to the pluripotent hESCs as control. 
For the primer detecting the ectodermal differentiation, glial fibrillary acidic 
protein (GFAP), sex determining region Y-box 1 (SOX1), orthodenticle homolog 2 
(OTX2) and paired box 6 (PAX6) were used while sex determining region Y-box 17 
(SOX17), brachyury (Brachyury), runt-related transcription factor 1 (RUNX1), 
pancreatic and duodenal homeobox 1 (PDX1) and cluster of differentiation 31 (CD31) 
were used as the endodermal and mesodermal differentiation markers. 
And for detection of neural induction, growth associated protein 43 (GAP43), β3-





3.8 Immunocytochemical analysis (ICC) 
The hESCs and hEBs were fixed with 4% PFA for 10 min at room temperature.  
After permeabilization using 0.25% PBST for 10 min at room temperature, the cells 
were blocked by 3% bovine serum albumin (BSA) in 0.1% PBST for 1 h at room 
temperature on a rocker.  The primary antibodies targeting especial maker proteins 
were diluted with 1% BSA in 0.1% PBST according to the manufacturer’s 
instructions, and the cells were treated with primary antibodies in solution, overnight, 
at 4 °C on a rocker.  In order to investigate pluripotency and self-renewal ability, 
anti-sex determining region Y-box 2 (SOX2) antibody (D6D9, Cell Signaling 
Technology, USA) and anti-NANOG antibody (D73G4, Cell Signaling Technology, 
USA) were used.  For the detection of ectodermal differentiation, anti-GFAP 
antibody (GF5, ab10062, Abcam, England) was used, while anti-Brachyury antibody 
(ab20680, Abcam, England) was used to confirm the endodermal and mesodermal 
commitments.  To identify neural induction, anti-GFAP antibody, anti-PAX6 
antibody (ab5790, Abcam, England) and anti-prospero homeobox protein 1 (PROX1) 
antibody (ab101851, Abcam, England) were used.  For detection of mechanisms of 
the accelerated neural induction, anti-glial cell line-derived neurotrophic factor 
(GDNF) antibody (ab18956, Abcam, England), anti-neural cell adhesion molecule 
(NACM) antibody (3606S, Cell Signaling Technology, USA), anti-microtubule-
associated protein 2 (MAP2) antibody (ab111267, Abcam, England) and anti-focal 
adhesion kinase (FAK) antibody (ab81298, Abcam, England) were utilized.  The 
hESCs and hEBs, exposed to primary antibodies, were subsequently treated with 
secondary antibodies for 1 h at room temperature and also with 4',6-diamidino-2-
34 
 
phenylindole (DAPI) for 5 min and then observed by confocal laser scanning 
microscopy (CLSM, Leica, Germany).  
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3.9 Western blotting 
After centrifuging the 3×105 cells at 1,200×g for 5 min, supernatant was discarded 
and the hESCs were re-suspended in 2 mM EDTA with PBS.  The cells were lysed 
via sonication with 23% amplification for 1 min (VCX500, Sonics & Materials, 
USA).  Then the lysates of the hESCs were separated into supernatant and pellets 
by centrifugation at 12,000×g for 20 min at 4 °C.  The pellets were incubated at 
100 ºC for 5 min in 2 mM EDTA with sulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE) protein loading buffer (Intron Biotechnology, USA).  Then the pellets 
were separated by electrophoresis on 10% SDS-PAGE gel and transferred to 
nitrocellulose blotting membranes (GE Healthcare Life science, Germany).  The 
blot was blocked with 5% BSA in 0.1% PBST for 1 h at room temperature and then 
incubated with primary antibody solution (1% BSA in 0.1% PBST with diluted 
primary antibody) at 4 ºC, overnight.  After incubation with horseradish peroxidase 
(HRP)-conjugated secondary antibody solution (5% BSA in 0.1% PBST) for 1 h at 
room temperature, the signals were detected with Luminata™ Western HRP 
Chemiluminescence Substrates (Millipore, USA) and G:BOX Chemi XL system 
(Syngene, Cambridge, UK).  The primary antibodies used for western blot analysis 
were anti-β-actin antibody (1:1000, ab8227, Abcam, England), anti-WNT3 antibody 





3.10 Statistical analysis 
The statistical analysis was conducted by using repeatedly drawn results from 
samples of all the groups.  The numbers of repetitions were 3 for genetical analysis, 
10 for quantification of ICC and 150 for morphological neurite analysis, respectively.  
The statistical significance was determined using an analysis of variance (t-test, 
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Chapter 4. Generation of size-controlled human embryoid 
bodies (hEBs) using magnetic nanoparticles (MNPs) 
4.1 Introduction 
Stem cells have been investigated for the clinical applications such as tissue 
engineering and regenerative medicine [3-5].  The development of stem cell-based 
treatments for incurable diseases has been thought to be promising.  In particular, 
human embryonic stem cells (hESCs) have been applied in tissue regeneration 
because of their unique ability for differentiation [6, 7].  Under defined conditions, 
the hESCs can differentiate into various cell types.  In spite of their prospective 
characteristics, hESCs are difficult to use in the practical applications because there 
have been unsolved problems that may arise after stem cell in vivo injection due to 
tumor formation as a result of heterogeneous differentiation [10-14].  Therefore, in 
order to make use of the fascinating properties of the hESCs, improved methods need 
to be developed for homogeneous differentiation of the hESCs into intended cell 
types. 
Recently, the hESC differentiation into specific and homogeneous cell types was 
accomplished.  However, achieving a high efficiency with homogeneous 
differentiation still remains a work in progress [15, 16].  To improve the control for 
particular lineages, hESC differentiation has made use of various chemical cues to 
induce designated signaling pathways [17-20].  In addition to such chemical factors, 
recently, controlling physical cues is also considered as a novel method in order to 
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delicately regulate the fate of the hESCs [21-23].  In particular, generating human 
embryoid bodies (hEBs), three-dimensional (3D) cell aggregates of the hESCs, is 
recognized as an ideal method to efficiently differentiate hESCs [15, 24-27].  Since 
the hEBs are generated in order to mimic the morphological similarity of developing 
embryos, hESCs in the form of hEBs are spontaneously induced into differentiation 
[28, 29]. 
In recent studies, researchers have suggested that the size of hEBs could play a 
significant role in the directing hESC lineage, because the hEBs with different 
diameters have shown distinct differentiation results [109-113].  Accordingly, the 
hEB generation has been attempted via various cell-clustering methods, including 
hanging-drop culture, non-adhesive surface culture, and porous 3D scaffold culture 
[30-33].  However, conventional cell-clustering methods have limitations in 
generating uniformly sized cell aggregates, and therefore microscale techniques have 
been suggested to achieve a more elaborate regulation [34].  Though the 
microfluidic devices [52-54] and microwells [55-57] have been widely used to 
generate uniform hEBs, there are still some limitations in microwells for hEB size 
control. 
In this study, the magnetic nanoparticle (MNP)-based magnetic force system was 
used to overcome those hurdles.  Major advantage of the MNP-based system is that 
it can instantaneously assemble the hESCs to make various sizes of hEBs.  Shorter 
time for cell gathering is critical because non-adherent single cells may undergo 
apoptosis during incubation.  Moreover, compared with microwells, precise 
40 
 
regulation of the hEB size is possible through the MNP-based concentrated magnetic 
force system, resulting in uniform hEB generation.  Anti-apoptotic assistants such 
as rho-associated protein kinase (ROCK) inhibitor are vital in the hEB generation 
using microwells, because the hESCs are prone to apoptosis when they are detached 
to be single cells.  However, the hEBs can be generated successfully using the 




4.2 Spheroid generation with human mesenchymal stem cells 
(hMSCs) and mouse ESCs (mESCs) 
To efficiently generate uniform spheroids of human mesenchymal stem cells 
(hMSCs) and mouse embryonic stem cells (mESCs), the MNPs isolated from 
magnetic bacteria and the concentrated magnetic force system were used (Figure 
4.2.1).  After purification, the MNPs dispersed in PBS were mixed with the cell 
culture medium, and the mixture was then applied to monolayered hMSCs and 
mESC, respectively.  Then, the MNPs were simply endocytosed into the cells.  
This intracellular delivery of MNPs was performed without additional modifications 
on MNP surfaces.  Then the magnetized cells, in which the MNPs were 
accumulated, were detached from the culture dishes using 0.25% trypsin-
ethylenediaminetetraacetic acid (TE) and added into the well of concentrated 
magnetic force system.  The concentrated magnetic force system was manufactured 
following the previous work [84].  Static magnets (10 mm × 5 mm × 6 mm) were 
placed on the cover of the plates, and iron pins were held by the magnetic force, 
under the cover.  The magnetically induced cells were driven toward the 
magnetized iron pinpoint after the lid had been closed, and the spheroids of hMSCs 
and mESCs that were generated respectively, floating just below the medium surface 
(Figure 4.2.2).  The size of the generated spheroids of stem cells was regulated in a 








Figure 4.2.1  Spheroid generation method using MNPs and concentrated magnetic 
force system.  After intracellular incorporation of the MNPs into the cells, the 
magnetized cells were added into a well of the concentrated magnetic force system.  
Then the cells move toward the concentrated magnetic force, resulting in generation 








Figure 4.2.2  Size-controlled spheroid generation with hMSCs and mESCs.  
Small and large spheroids of the hMSCs and mESCs were produced, respectively.  
And their size was regulated by controlling the number of cells added in a well of 
the concentrated magnetic force system.  White scale bars indicate 20 μm, and 
black scale bars indicate 200 μm, respectively. 
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4.3 Limitation of hEB generation 
Like the spheroid generation method with hMSCs and mESCs which was 
mentioned above, the MNPs isolated from magnetic bacteria and the concentrated 
magnetic force system were utilized in order to efficiently generate precisely 
regulated and uniform hEBs.  However, different from the spheroid generation with 
hMSCs and mESCs, hEB generation via MNPs had a problem. 
A mixed solution of MNP-dispersed PBS and the hESC culture medium was 
treated with colony-shaped hESCs which were cultured as a monolayer with feeder 
cells according to the conventional culture method of the hESCs.  Similar to the 
spheroid generation with hMSCs and mESCs described previously, MNPs were 
treated overnight with the hESCs and then chemicals were treated with the hESCs to 
detach them from the culture dishes.  First, when cells were separated by TE 
treatment as in other cells, the feeder cell, STO, fell off together, making it difficult 
to use only the hESCs.  Therefore, collagenase was treated for 30 min to isolate 
only colony-typed hESCs first.  Additionally, the isolated hESC colonies were 
disrupted at the single cell level through accutase treatment.  Thus the magnetized 
hESCs obtained were added into the wells of the concentrated magnetic force system. 
Considering that the time taken for cell moving toward the concentrated magnetic 
force and then the cell aggregate formation was several seconds to several minutes 
in case of hMSCs and mESCs, the hEB generation was not observed after several 
hours.  Although floating hESCs were observed near the pinpoint, they did not form 
a solid hEBs and most of the hESCs added into the well were observed to sink to the 
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bottom (Figure 4.3.1).  The color of the floating cells at the pinpoint just below the 
surface of the medium were black or dark gray, whereas the sunken cells were white.  
This indicates that the hESCs which were incorporated with the MNPs (the color of 
the cells were dark) existed in a floating form below the surface and the amount was 
small compared with the amount of total cells added into a well.  However, majority 
of the added hESCs were non-magnetized cells (the color of the cells were bright) 
which did not have incorporated-MNPs, and they were sunk to the bottom of the 
wells. 
After cell adding to wells of the concentrated magnetic force system, suspended 
cells were observed continuously for several hours to several days, but still organized 








Figure 4.3.1  Limitation of hEB generation using MNPs and concentrated magnetic 
force system.  The sufficiently magnetized cells (dark colored) were suspended just 
below the medium surface by the concentrated magnetic force, while non 
magnetized cells (bright colored) were sunken at the bottom of wells.  And the 
amount of the sunken cells was large compared with the suspended cells.  Scale 




4.4 Cytotoxicity and intracellular incorporation of MNPs 
Because majority of the hESCs to which the MNPs were treated remained non-
magnetized (the color of the cells were white), intracellular properties of the MNPs 
to the hESCs were investigated through cytotoxicity test and intracellular 
incorporation analysis. 
First, cytotoxicity of the MNPs on hESCs was compared with hMSCs (Figure 
4.4.1).  After the MNPs had been directly applied to the hMSCs and hESCs over a 
wide range of concentrations, they were incubated with cells for 24 h, respectively.  
And the cell viability was then detected.  The concentration of the MNPs, which 
were mixed with the cell culture medium as dispersed form in PBS, ranged from 5 
to 50 μg/ml.  The cell viability of the hMSCs decreased along increase of the MNP 
concentrations.  When the concentration of the MNPs over 40 μg/ml, cell viability 
was reduced under 85%.  However, the hESCs did not show significant cell death 
regardless of the MNP concentrations when compared to the non-treated cells. 
Based on this, presence and the location of MNPs introduced into the hESCs were 
investigated comparing with the hMSCs (Figure 4.4.2).  The transmission electron 
microscopy (TEM) analysis and Prussian blue staining analysis were conducted to 
verify the difference in the MNP incorporation.  In a hMSC, plenty of the MNPs 
were located within vesicle-like structures.  However, there was no MNPs observed 
in a hESC.  Furthermore, intracellularly delivered MNPs showed positive for 










Figure 4.4.1  Cytotoxicity of MNPs on hMSCs and hESCs, respectively.  (A) The 
hMSCs showed decreased cell viability under 100% (which was the cell viability of 
the untreated cells), when more than 30 μg/ml of the MNPs were treated to the cells.  
(B) On the other hand, the hESCs did not show any decrease of the cell viability 







Figure 4.4.2  Intracellular incorporation of MNPs in hMSCs and hESCs, 
respectively.  (A) The TEM image of the hMSCs showed a lot of the MNPs 
incorporated in the cells, in vesicle-like structures.  Rectangles of red dotted lines 
represent expanded image from left to right.  In the Prussian blue staining image, 
the iron ion from the MNPs included in the hMSCs were stained as blue, when the 
hMSCs were counterstained as red.  (B) In the TEM image of the hESCs cultured 
with feeder cells, the MNPs incorporated in the cells were not observed.  Also in 
Plussian blue staining image, only the counterstained hESCs were observed, while 




blue staining all over the colonies.  Therefore, poor incorporation of the MNPs into 





4.5 Effect of feeder cells on intracellular uptake of MNPs into 
hESCs 
In the preceding study, intracellular delivery of MNPs into the hMSCs and mESCs 
was easy and simple, whereas the MNPs were not easily introduced into the hESCs.  
In order to identify the cause of this problem, especially occurring only in the hESCs 
different from other stem cells, and to find a solution, the specific culture condition 
of hESCs was considered.  According to the conventional culture method of the 
hESCs, they were cultured with other cells called “feeders” or “feeder cells” to 
remain pluripotency (Figure 4.5.1) [107].  After inner cell mass was isolated from 
embryo at blastocystic stage, the cells were transferred to in vitro cell culture dish in 
which feeder cells were attached in advance [10, 16, 107, 114].  With the feeders, 
the hESCs maintaine their pluripotency, even though the accurate effect and the role 
of the feeder cells on the hESC culture have been unknown. 
In this conventional method, the hESCs existed in the form of colonies, in which 
the cells were in close proximity to each other, resulting in a small cytosolic volume.  
Thus, cultivation of the hESCs with feeder cells, inducing the decrease of cellular 
volume, needed to be improved for the intracellular incorporation of the MNPs.  As 
a novel culture method for hESCs, feeder-free system was applied, in which the 
hESCs were cultured without feeder cells but extracellular matrices (ECM), 
represented as Geltrex™, were used instead of the feeders.  Without the feeders, 
the colonies of hESCs were made loose and thus the cytosolic volume of the hESCs 







Figure 4.5.1  Conventional culture of hESCs.  Schematics of the hESC isolation 





existence of feeder cells and thus in order to detect the effect of feeder cells on 
intracellular introduction of the MNPs into the hESCs, conventional hESC culture 
method and the feeder-free system were compared through Prussian blue staining 
and TEM analysis (Figure 4.5.2 A and B, respectively).  According to the Prussian 
blue staining, unlike the hESCs in compact colonies with feeder cells, feeder-free 
hESCs showed improved incorporation of the MNPs.  In conventional culture, only 
the MNP-introduced feeder cells were stained as blue, which were surrounding the 
hESC colonies.  However, a lot of feeder-free hESCs were stained as blue.  In 
TEM images, a conventionally cultured hESC did not show any MNPs which were 
accumulated in a cell, whereas a hESC cultured without feeder cells possessed some 
clusters of the MNPs located in vesicle-like structures.  As a result of the reduced 
compact junction between cells, the cytosolic volume of the cells increased, and 






Figure 4.5.2  Effect of feeder cells on MNP incorporation into hESCs.  The MNP 
incorporation in hESCs with or without the feeder cells was compared through 
Prussian blue staining (A) and TEM analysis (B).  Scale bars indicate 200 μm, 100 
μm, 2 μm, 1 μm and 200 nm, respectively. 
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4.6 Optimization of hEB generation method 
As previously described, MNP accumulation into the cytosols of the hESCs was 
enhanced by removing the compact colony construction via feeder-free system.  
Therefore, the hEB generation method using the MNPs and the concentrated 
magnetic force system was optimized as below (Figure 4.6.1).  The hESCs were 
cultured with feeder cells to maintain their pluripotency and the hESCs without 
feeder cells were used for the MNP addition procedure for the efficient hEB 
generation.  Thus, the hESCs cultivated with feeders were transferred onto feeder-
free system, 5 to 7 days before the MNP treatment.  Then the hESCs without feeders 
were magnetized through intracellular incorporation of the MNPs.  Even though 
the intracellular delivery of MNPs was improved through feeder-free system, the 
hESCs need sufficient cytosolic incorporation of the MNPs for complete 
magnetization by which the hEB generation using MNPs would be practical.  
Actually, because of the small cytosolic volume of the hESCs compared with other 
mammalian cells, only about 10% of the hESCs, to which the MNPs were treated, 
were sufficiently incorporated with MNPs.  Thus, the sufficiently magnetized 
hESCs were separated using magnetic force.  After the overnight incubation with 
the MNPs, the hESCs were detached and the suspending cells were transferred to 
fresh 1.5 ml tube.  Then, the 200 mT static magnets were applied to the tube 
containing the cell solution for 1 min.  Only the sufficiently magnetized hESCs 
moved toward the magnets.  Since only the hESCs possessing magnetically driven 
mobility were retained at the tube wall by the NdFeB magnets, other cells remaining 






Figure 4.6.1  Optimized hEB generation method using MNPs and concentrated 
magnetic force system.  For improved intracellular delivery of the MNPs into the 
hESCs, the feeder-free system was applied.  Furthermore, only the sufficiently 
magnetized hESCs were magnetically isolated and then they were added into the 
wells of the concentrated magnetic force system. 
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from the tube, and the magnetized cells were re-suspended in hEB medium.  These 
sorted hESCs were then added into wells of the concentrated magnetic force system 
to generate the hEBs. 
In the process of MNP treatment to the hESCs, the MNP concentration was fixed 
depending on amount of the cells which were sufficiently magnetized through 
magnetic sorting of the hESCs.  Even when the concentration of the MNPs was 
higher than 20 μg/ml, the proportion of the sufficiently magnetized hESCs did not 




4.7 Generation of hEBs depending on cell concentration and 
incubation time 
The MNPs and the optimized concentrated magnetic force system which was 
described above were used to generate hEBs efficiently.  And the size of the hEBs 
could be regulated by controlling the number of cells added in a well.  The 
correlation of the number of cells added in a well and the diameter of the hEBs was 
investigated depending on the incubation time after cell addition to the concentrated 
magnetic force system.  As shown in Figure 4.7.1, the size of the hEBs was 
determined by the total number of cells added into a well.  The hEB produced from 
5,000 cells of the hESCs was 100 μm in diameter, and 10,000 cells of the hESCs 
generated a hEB, diametered 150 μm.  The hEB made from 50,000 hESCs was 300 
μm in diameter, and the hEB generated with 500,000 cells was 800 μm in diameter.  
Furthermore, we found that larger hEBs required a longer incubation time for a 
tighter cell aggregation.  Up to ten thousand cells of hESCs were concentrated in 
several seconds, and they were easily gathered within 3 days.  On the other hand, 
more than 10,000 cells of the hESCs were not immediately concentrated but they 
assembled gradually for 3 days, resulting in compact masses.  The construction of 
the hEBs was solidly rearranged according to the incubation time.  After 3 days of 
hEB generation, the hESCs were adequately aggregated independently of the cell 








Figure 4.7.1  Effect of cell numbers and incubation time on hEB generation.  The 
hEBs were organized depending on the cell numbers added into a well of the 
concentrated magnetic force system, and they were observed according to the 
incubation time after the cell addition.  As the number of added cells increased, the 
final size of the hEBs also increased.  And the hEBs were reorganized, resulting in 
compactly agglomerated hEBs as time passed.  Scale bars indicate 200 μm. 
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4.8 Small and large hEB generation 
According to previous studies reporting that the initial size of the hEBs might be 
a critical factor influencing the early differentiation of the hESCs, a size of 300 μm 
was hypothesized as a significant point to determine the direction of the lineage-
specific differentiation.  Consequently, the criteria for the hEB size were defined as 
below.  For a small hEB, the diameter was determined as 150 μm which means half 
of the 300 μm, and for a large hEB, the diameter was decided as 600 μm which is 
twice of the 300 μm. 
A theoretical calculation on the basis of the correlation between the cell number 
per well and the hEB size was used to determine accurate cell numbers for small and 
large hEBs.  The number of magnetically induced cells which were added into a 
well of the concentrated magnetic force system was 1 × 104 for a small hEB whose 
diameter was 150 μm.  And 16 × 104 cells of the hESCs were utilized to generate a 
large hEB, 600 μm in a diameter.  Based on these, the small and large hEBs were 
generate respectively, and the core of the compactly agglomerated hEBs appeared to 








Figure 4.8.1  Small and large hEB generation.  Based on the calculated 
correlation of the cell number added in a well and the hEB size, size-controlled hEBs 
were produced.  10,000 cells of the sufficiently magnetized hESCs were added in a 
well of the concentrated magnetic force system to generated small hEBs (150 μm in 
diameter).  And 160,000 cells were added for large hEBs (600 μm in diameter).  





In this study, uniformly shaped spheroids of stem cells were generated using the 
MNPs isolates and then purified from magnetic bacteria, Magnetospirillum sp. 
AMB-1.  By treating the MNPs to hMSCs and mESCs overnight, MNPs were 
incorporated into the cells and thus the stem cells were efficiently magnetized.  
Then, the magnetized cells were added into wells of the concentrated magnetic force 
system to produce spheroids of hMSCs and mESCs, respectively.  Because the 
MNP-introduced cells were moved by driven force of the concentrated magnetic 
force system, cells were gathered generating cell aggregates at the pinpoint.  By 
controlling the cell numbers added in a well, the size of the spheroids of hMSCs and 
mESCs was easily regulated. 
Unlike other stem cells represented as hMSCs and mESCs, the hESCs were 
difficult to generate as spheroids, called “hEBs”, due to the small amount of the 
MNPs accumulated therein.  Only small proportion of the hESCs, which were 
treated with the MNPs, were magnetized and suspended below the surface of the 
medium in the concentrated magnetic force system.  On the other hand, majority of 
the added cells were not magnetized and sank at the bottom of the wells. 
Thus intracellular properties of the MNPs were detected in hESCs compared with 
hMSCs.  The cytotoxicity of the MNPs on hESCs was not observed regardless of 
MNP concentrations, whereas the cell toxicity of the MNPs increased in hMSCs 
according to their concentrations.  And the MNPs were not observed in hESCs, 




Typically, the hESCs have been cultured in the form of compact colonies 
surrounded by feeder cells, which have been considered to be essential for 
maintaining pluripotency of the hESCs.  In those colonies, the hESCs were in close 
proximity to each other leading to decreased surface area and volume.  Thus, 
intracellular delivery and cytosolic accumulation of the MNPs were difficult in those 
colony-shaped hESCs.  To solve this insufficient incorporation of the MNPs and 
inadequate magnetization of the hESCs, feeder-free system was applied.  By 
replacing the feeder cells as Geltrex™, the colonies of the hESCs was made loose, 
resulting in the improved intracellular incorporation of the MNPs. 
To generate hEBs efficiently using the MNPs, the hESCs without feeders were 
utilized during MNP treatment process, and then sufficiently magnetized cells were 
isolated by static magnet separation.  Through this optimization of the MNP-based 
concentrated magnetic force system, the hEBs could be generated efficiently. 
The size of the hEBs was uniformly regulated by controlling the cell numbers 
added into a well of the concentrated magnetic force system.  Through verifying 
the number of hESCs which were sufficiently magnetized, and the incubation time 
after adding the cells into a well, the correlation of the cell number and hEB size was 
detected.  As the number of the magnetized cells added into a well increased, 
diameter of the hEBs expanded.  And the resulting hEBs were compactly organized 
according to the incubation time. 
As a result, based on theoretical calculations, the hEBs of two sizes were generated; 
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10,000 cells for small one, 150 μm in diameter and 160,000 cells for large one, 600 
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Chapter 5. Lineage-specific differentiation by controlling the 
size of human embryoid bodies (hEBs) 
5.1 Introduction 
As briefly mentioned above, controlling the size of human embryoid bodies (hEBs) 
is crucial for homogeneous and lineage-specific differentiation of the human 
embryonic stem cells (hESCs) [109-113].  In chapter 4, the magnetic nanoparticle 
(MNP)-based concentrated magnetic force system, which was optimized with 
feeder-free system and magnetic cell sorting, was utilized for the assembly of hESCs 
into hEBs with uniform size distribution.  This precise formation based on 
magnetic control allowed facile and prompt hEB generation.  It also facilitates 
high-throughput and largescale hEB generation.  This advanced hEB generation 
method improves cell-to-cell contact by external magnetic force and thus, the size of 
fabricable hEB was wide in range (up to 600 μm in diameter) without assistance of 
anti-apoptotic assistants such as rho-associated protein kinase (ROCK) inhibitor.  
Furthermore, the hEB size could be controlled with accurate cell number added in a 
well of the concentrated magnetic force system, because the percentage of the 
aggregated cells among total cells added in a well constantly remained at 85%. 
In this study, the effect of the hEB size on early commitments of the hESCs was 
detected.  And thus, the homogeneous cell population was obtained in terms of the 




5.2 Down regulation of pluripotency in hEBs 
In chapter 4, precisely sized hEBs were generated using the MNPs and the 
concentrated magnetic force system.  And their sized were determined based on the 
studies reporting the effect of initial hEB size on lineage specification of the hESCs.  
According to the previous work, a size of 300 μm in a diameter was hypothesized as 
a significant point to determine the direction of the lineage-specific differentiation 
[109-113].  So, small hEBs were generated, 150 μm in a diameter smaller than 300 
μm, and large hEBs were produced, 600 μm in a diameter larger than 300 μm. 
In order to define the direction of differentiation in the hEBs of two sizes, 
spontaneous differentiation was induced and differentiation aspects were 
investigated.  The differentiation of small and large hEBs was induced for 3 days 
in hEB medium without any chemical inducers.  And then the differentiation 
patterns were observed via genetic analysis and immunocytochemical analysis (ICC).  
The primers used in real time reverse transcription-polymerase chain reaction (RT-
PCR) for genetical analysis are as in Table 5.1. 
First, the pluripotency (i.e., the ability of cell to differentiate into various cell types) 
was investigated because it is one of the most significant properties of natural hESCs.  
As in previous studies, pluripotency is an intrinsic feature of the hESCs and would 
therefore, decrease as differentiation proceeds [10, 16, 107].  Regarding the effect 
of the MNPs themselves on differentiation, we observed that the hESCs with MNPs 
did not show significant difference in pluripotency, when cultured in stem cell 











pluripotency of the hEBs was detected according to the expression level of OCT4 
using RT-PCR (Figure 5.2.1).  The OCT4 expression in small and large hEBs was 
significantly down-regulated, compared to undifferentiated hESCs.  Furthermore, 
pluripotency and self-renewal ability of the hESCs and the hEBs were detected using 
ICC for other pluripotency markers such as SOX2 and NANOG (Figure 5.2.2).  
Contrary to the undifferentiated hESCs, the hEBs did not show any expression of 
both SOX2 and NANOG, indicating the lost of pluripotency with the progress of 
differentiation.  Consequently, hESCs in the form of hEBs were definitely induced 





Figure 5.2.1  Genetical analysis of pluripotency in hESCs and hEBs.  According 
to the agarose gel data of RT-PCR (A), and the quantitative data of real time RT-PCR 
(B), the pluripotency represented by genetical expression level of OCT significantly 
decreased in both sizes of hEBs compared with undifferentiated hESCs.  *** 






Figure 5.2.2  ICC of pluripotency in hESCs and hEBs.  The pluripotency 
represented by protein expression of SOX2 (red fluorescence) and NANOG (green 




5.3 Ectodermal differentiation of hEBs 
Although both small and large hEBs underwent down regulation in their 
pluripotency, their fate was determined differently.  The fate of the hESCs was 
evaluated by representative markers of three germ layers; ectoderm, endoderm and 
mesoderm. 
First, the expression of ectodermal marker genes, including glial fibrillary acidic 
protein (GFAP), sex determining region Y-box 1 (SOX1), orthodenticle homolog 2 
(OTX2) and paired box 6 (PAX6), was investigated in the hESCs, small and large 
hEBs (Figure 5.3.1).  Through the agarose gel band after electrophoresis, 
expression of the ectodermal markers was enhanced in small hEBs compared with 
the undifferentiated hESCs and large hEBs.  And according to the quantitative 
analysis via real time RT-PCR in which the results were normalized by each value 
of the control, both small and large hEBs showed a remarkable increase in the 
expression of GFAP and SOX1 relative to the undifferentiated hESCs.  Furthermore, 
their expression in small hEBs indicated statistically significant differences 
compared to the large hEBs.  The GFAP expression level increased by 2.5-fold in 
small hEBs compared with the large hEBs, and the SOX1 expression level increased 
by 5.2-fold in small hEBs relative to large hEBs.  In addition, the expression of the 
ectodermal protein, GFAP, was analyzed via the ICC (Figure 5.3.2).  The nuclei 
were described in both the small and large hEBs as a blue fluorescence while the 





Figure 5.3.1  Genetical analysis of ectodermal differentiation in small and large 
hEBs.  (A) According to the agarose gel data of RT-PCR, the ectodermal 
differentiation represented by the expression of GFAP, SOX1, OTX2 and PAX6 was 
enhanced in small hEBs compared to the hESCs and large hEBs.  (B) In 
quantitative data of real time RT-PCR, the ectodermal differentiation indicated by 
relative expression level of GFAP and SOX1 significantly increased in small hEBs 







Figure 5.3.2  ICC of ectodermal differentiation in small and large hEBs.  The 
ectodermal differentiation represented by protein expression of GFAP (green 
fluorescence) was enhanced in the small hEBs compared with the large hEBs.  The 




5.4 Endodermal and mesodermal differentiation of hEBs 
The endodermal and mesodermal differentiation in both small and large hEBs was 
genetically analyzed as in Figure 5.4.1.  The expression of endodermal and 
mesodermal differentiation marker genes, including sex determining region Y-box 
17 (SOX17), brachyury (Brachyury), runt-related transcription factor 1 (RUNX1), 
pancreatic and duodenal homeobox 1 (PDX1) and cluster of differentiation 31 
(CD31), was investigated in the hESCs, small and large hEBs.  Through the agarose 
gel band after electrophoresis, expression of the endodermal and mesodermal 
markers was obviously enhanced in large hEBs compared with the undifferentiated 
hESCs and small hEBs.  The result of quantitative analysis via real time RT-PCR 
indicated that both small and large hEBs clearly showed an enhanced expression of 
SOX17, Brachyury and RUNX1 when compared with the undifferentiated hESCs.  
Furthermore, their expression in large hEBs indicated statistically significant 
increases compared to the small hEBs.  The SOX17 expression level increased by 
1.8-fold in large hEBs when compared with small hEBs.  Moreover, the Brachyury 
expression level increased by 1.7-fold, and the RUNX1 expression level increased 
by 3.2-fold in large hEBs compared with the small hEBs.  The expression of a 
typical mesodermal protein, Brachyury, was analyzed via ICC (Figure 5.4.2).  The 
nuclei were described in both the small and large hEBs as a blue fluorescence while 





Figure 5.4.1  Genetical analysis of endodermal and mesodermal differentiation in small and large hEBs.  (A) According to the agarose gel data 
of RT-PCR, the endodermal and mesodermal differentiation represented by the expression of SOX17, PDX1, Brachyury and CD31 was enhanced 
in large hEBs compared to the hESCs and small hEBs.  (B) In quantitative data of real time RT-PCR, the endodermal and mesodermal 
differentiation indicated by relative expression level of SOX17, Brachyury and RUNX1 significantly increased in large hEBs when compared with 







Figure 5.4.2  ICC of endodermal and mesodermal differentiation in small and large 
hEBs.  The endodermal and mesodermal differentiation represented by protein 
expression of Brachyury (red fluorescence) obviously enhanced in the large hEBs 





5.5 Effect of hEB size on cell death and lineage-specific 
differentiation 
By aggregating the hESCs using MNPs and the concentrated magnetic force 
system, they were spontaneously differentiated in the form of hEBs.  The 
pluripotency of the hESCs was significantly down-regulated and lineage-specific 
differentiation was observed according to hEB size in the hEB culture medium, 
which does not determine the direction of differentiation.  As a result, small hEBs 
showed enhanced ectodermal differentiation compared with the large hEBs, and 
large hEBs showed improved endodermal and mesodermal differentiation relative to 
the small hEBs.  
To verify the differences between these hEBs of two sizes, core cell death aspects 
was investigated depending on diameter of the hEBs (Figure 5.5.1).  It was 
predicted that the core part of the hEBs would have limitations in transfer of the 
nutrient and oxygen according to the hEB size.  In small and large hEBs, live 
hESCs were shown as green, whereas dead cells were shown as red, respectively.  
There was significant cell death in the core of large hEBs while almost all cells were 
alive in small hEBs.  In the large hEBs, fluorescence is not expressed at the core, 
and thus it appears black because dye could not penetrate the thick cell layer, 








Figure 5.5.1  Cell death patterns in hEBs depending on their size.  The cell death 
was investigated in both small and large hEBs.  Live and dead hESCs were shown 
as green and red fluorescence, respectively.  There was significant cell death in the 
core of large hEBs while almost all cells were alive in the small hEBs.  Scale bars 





By gathering the cells and forming hEBs, the hESCs lose pluripotency, which is 
an intrinsic feature of the hESCs, regardless of the hEB sizes.  In hEB culture 
medium without any inducer directing differentiation lineage, hEBs of both sizes 
were spontaneously differentiated.  After 3-day-long spontaneous differentiation in 
suspended condition, the differentiation patterns of the small and large hEBs were 
investigated. 
The expression of ectodermal genes represented as GFAP, SOX1, OTX2 and PAX6, 
was significantly enhanced in small hEBs compared with large hEBs.  And 
ectodermal protein GFAP were intensively expressed in small hEBs compared to 
large hEBs. 
On the other hand, the expression of endodermal and mesodermal genes 
represented as SOX17, Brachyury, RUNX1, PDX1 and CD31, was significantly 
increased in large hEBs relative to small hEBs.  And the expression of mesodermal 
protein Brachyury was up-regulated in large hEBs compared to small hEBs. 
To identify the cause of these differences in differentiation direction depending on 
the hEB size, cell death in hEBs was investigated.  The diameter of the hEBs had a 
significant effect on cell viability in core part of the hEBs.  Many cells were found 
to be dead in the center of large hEBs and led to formation of lumens. 
Thus, as described in Figure 5.6.1, the initial size of the hEBs was crucial for 








Figure 5.6.1  Lineage-specific differentiation of hEBs depending on their size.  
Small hEBs (150 μm in diameter) were differentiated into ectodermal lineage, while 





that through various chemical and biological factors induced by the hEB size-
dependent signals, the small hEBs began to differentiate into ectodermal lineages, 
which should be preceded for the differentiation into skin cells and nerve cells, 
whereas the large hEBs differentiated into endodermal and mesodermal lineages, 
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Chapter 6. Neural induction of small-sized human embryoid 
bodies (hEBs) 
6.1 Introduction 
Nerve cells are largely divided into two groups; neurons and non-neurons [115-
117].  Nerve cells that perform the neurological functions which are actively 
involved in neuronal transmission are neurons [118, 119].  On the other hand, non-
neuronal cells, called glial cells, help the neurons with their proper function.  They 
maintain the homeostasis of the nervous system, support the structures of nervous 
system, and protect the neurons [120, 121].  In neurogenesis with the human 
embryonic stem cells (hESCs), the ultimate targets are usually neurons with the 
function of neurotransmission, though various glial cells such as oligodendrocytes 
could be the differentiation purpose. 
In the hESC-based neurodevelopmental studies, it is common to utilize the human 
embryoid body (hEB) forms, called neurospheres, for the improved differentiation 
(Table 6.1) [122].  This seems to be due to the fact that the hEBs mimic the stiffness 
of the brain tissue which is very soft among the body tissues (Figure 6.1.1) [123, 
124].  In other words, it is a worthy strategy to facilitate neural induction by 
providing similar physical environment. 
In the previous chapter, a successful technology for hEB generation was 
developed and the effect of hEB size on the direction of initial differentiation of the 























the ectodermal differentiation was promoted in small hEBs with a diameter of 150 
μm, and endodermal and mesodermal differentiation was improved in large hEBs of 
600 μm in diameter.  This lineage-specific differentiation occurred spontaneously 
in the hEB medium without any inducers for specific differentiation.  The 
spontaneously differentiated small hEBs in hEB medium were ectodermally induced 
and they showed enhanced glial fibrillary acidic protein (GFAP) expression.  
Moreover, some of these GFAP-positive cells showed neurite-like outgrowth (Figure 
6.1.2).  Therefore, in this chapter, the hESCs were neurally induced in the form of 
the small-sized hEBs using the magnetic nanoparticles (MNPs) and the concentrated 









Figure 6.1.2  Spontaneous neurite-like outgrowth of small-sized hEBs.  Some of 
the ectodermally differentiated small hEBs, which were positive to GFAP expression, 
showed neurite-like outgrowth.  So, the improvement of neural induction of the 
hESCs was conducted in the form of hEBs using the MNPs and the concentrated 




6.2 Neural induction method for hESCs using MNPs 
6.2.1 Neural induction of small-sized hEBs 
In this study, the hESCs were neurally induced in the form of small-sized hEBs 
using the MNPs and the concentrated magnetic force system.  Through previous 
work, it was already revealed that the initial size of hEBs is important for the lineage-
specific differentiation of the hESCs in early stage and that the small-sized hEBs, 
150 μm in diameter, is spontaneously differentiated into ectodermal lineages.  
Because ectodermal differentiation should be preceded for the neural induction [125, 
126], the small-sized hEBs were used for the improved neural induction (Figure 
6.2.1.1).  And the hEB culture medium which was utilized for spontaneous 
differentiation of the hEBs in former chapter, was replaced to neural induction 
medium (NIM) for the improved neural induction.  Furthermore, duration of the 
cultivation for the hESC differentiation was 3 days for the spontaneous induction but 
in the neural induction, the duration of cultivation was increased to 5 days.  So, the 









Figure 6.2.1.1  Neural induction of small-sized hEBs.  In order to neurally induce 
the hESCs, hEB generation method utilizing the MNPs and the concentrated 
magnetic force system was applied for small-sized hEB (150 μm in diameter) 
production.  And the hEB medium used in spontaneous differentiation was replaced 




6.2.2 Experimental groups 
To investigate the improvement of the neural induction of small-sized hEBs 
cultured in NIM under suspended condition for 5 days (Ⅳ), comparable groups were 
set as follows (Figure 6.2.2.1); undifferentiated hESCs (Ⅰ), conventionally 
differentiated hESCs with NIM (Ⅱ), and conventionally differentiated hESCs with 
NIM and MNPs (Ⅲ).  The undifferentiated hESCs (Ⅰ), which were maintained in 
pluripotency state, became a control group.  The neurally induced hESCs using 
only the NIM (Ⅱ), following the most general method of neural induction, became 
the comparative test group.  Because there were two different factors, such as 
addition of the MNPs and three-dimensional (3D) cultivation in group Ⅳ, compared 
with Ⅱ, a new experimental group, two-dimensionally (2D) cultured hESCs 
differentiated with NIM and the MNPs (Ⅲ), was added.  As a result, the effect of 
the small-sized hEB generation method using the MNPs and the concentrated 
magnetic force system on neural induction was examined; comparing the 
improvement of neural induction in Ⅳ with other groups.  And also the effect of 
3D culture on the improvement of neural induction could be investigated by 
comparing Ⅳ and Ⅲ.  Furthermore, by comparing the Ⅲ with Ⅰ and Ⅱ, the synergic 








Figure 6.2.2.1  Schematics for experimental groups.  The undifferentiated hESCs 
were the control (Ⅰ), and conventionally differentiated hESCs with NIM were group 
Ⅱ.  The hESCs differentiated with NIM and the MNPs were Ⅲ.  And the small-




6.3 Morphological analysis 
6.3.1 Morphology of hESCs 
As an indicator detecting the neural induction of 4 experimental groups, 
morphological analysis was performed to observe, compare and analyze the 
appearance of the hESCs.  Thus, the superficial morphology of the cells and the 
number and length of the neurites sprouted from the cells were investigated. 
First, morphological differences among the cells were observed.  The 
morphological characteristics of the natural hESCs are that the shape of the cells is 
round and the size of the cells is very small compared to the other mammalian cells; 
less than 10 μm in diameter [9, 16].  The hESCs, which are cultured with feeder 
cells, grow in compact colonies.  The feeder-free hESCs grow in colony-shapes 
either, though the colonies are made loose slightly.  A significant change in the 
progression of neuronal differentiation is the formation of tiny projections on cells, 
called “neurites” [127-130].  When a hESC becomes a neuron, the morphology 
becomes sharp-pointed like a star.  In the process of differentiation into such a 
neuron, neurites are necessarily found.  In general, neurons do not colonize like the 
hESCs.  Instead of forming compact colonies, there is enough intercellular space 
between the neuronal cells.  But when the neurons are matured, intercellular 
interactions could be active, which leads to the improvement of intercellular 
connections. 
Based on these, shape of the cells in 4 experimental groups was investigated 
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(Figure 6.3.1.1).  In the control group, undifferentiated hESCs (Ⅰ), the typical 
appearance of hESCs described above, was observed.  The cells formed a colony 
and maintained a round-shaped appearance.  However, it was observed that the 
rounded cells and the triangular cells with pointed parts co-existed in Ⅱ, in which the 
angular cells existed where the cell density was low, far from the colony.  In Ⅲ and 
Ⅳ, many of the angular cells were observed and prominent neurite protrusions were 
shown.  It was possible to observe not only one neurite but also several neurites 
sprouting from one cell, and some of the neurites were extremely long, resulting in 
enlarge the length of the whole cell.  Also in group Ⅳ, I observed cell aggregates, 
which were some parts of the attached hEBs.  To investigate the morphology of the 
suspending hESCs in the form of 3D, the hEBs were made sunk to the bottom of the 
wells, resulting in not only the adherence of the hEBs but also the migration of the 
exterior cells away from the center.  The squares with the yellow dotted lines 
indicated cells that migrated away from the adhered hEB mass, whereas the squares 





Figure 6.3.1.1  Morphology of hESCs in 4 experimental groups.  The shape of cells was observed in all of the experimental group by 
microscope.  Scale bars indicate 200 μm.  
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6.3.2 Number of neurites per cell 
To quantify the neurite-related cell morphology, which was observed through 
microscope above, the number of neurites per cell was examined.  To determine the 
number of neurites from the hESCs, 150 cells per each experimental group were 
analyzed.  According to the Table 6.2, proportion of the cells according to the 
number of neurites was investigated.  Then the average number of neurites per cell 
was calculated in Figure 6.3.2.1. 
In the control group, undifferentiated hESCs (Ⅰ), all of the cells remained spherical, 
resulting in the absence of neurite-extending cells. 
In the hESCs conventionally differentiated using NIM for 5 days (Ⅱ), more than 
half of the cells existed without any neurites (64.1%), but the neurites were found in 
rest of the cells, and the hESCs with more than two neurites were also found.  The 
percentage of cells with one neurite per cell was 18.9%, two neurites per cell was 
6.8%, and the ratio of the cells with three or more neurites was 10.2%.  The 
calculated average number of neurites per cell was 0.45, when total cells, including 
the hESCs without neurite, were investigated.  However, except for the cells 
without neurite (64.1%), the average number of neurites per cell was 1.90. 
In the hESCs neurally induced using NIM and the MNPs (Ⅲ), the proportion of 
neurite-free cells was only 9.6%, and thus 90.4% of the cells were observed to 
possess neurites.  In group Ⅲ, 33.8% of the cells had one neurite per cell, 25.0% of 
cells had two neurites, and 31.6% of the cells had three or more neurites per cell.  

















Figure 6.3.2.1  Average number of neurites per cell.  Both in total cells, including 
the cells without neurites, and in cells sprouting neurites, the average number of 





1.31 in total cells including neurite-free cells, whereas the average value of only 
neurite-observed cells was 1.54. 
In the neurally induced hEBs using NIM (Ⅳ), the percentage of cells without 
neurite was only 10.5%, similar to Ⅲ.  The percentage of cells with one neurite per 
cell was 14.3%, the cells with two neurites was 30.5%, and the cells with three or 
more neurites was 44.7%.  The ratio of three or more neurites out of one cell was 
highest in IV compared to the other groups.  The average number of neurites per 
cell was calculated to be 1.94 for total cells containing the cells without neurite in 
Ⅳ, and 2.50 for only the cells with neurites. 
As a result, from experimental group Ⅰ to Ⅳ, the ratio of neurite-free cells 
significantly decreased, while the proportion of cells with neurites increased 
remarkably.  In particular, the ratio of cells with more than one neurite has been 
greatly improved.  In addition, the average number of neurites per cell also 
increased toward the end group.  When calculating the total cells, number of 
neurites per cell in Ⅲ was statistically increased compared with Ⅱ, resulting in 2.9-
fold to the group Ⅱ (p < 0.001).  And the average number of neurites of total cells 
in Ⅳ was significantly increased compared to Ⅲ, resulting in 1.5-fold of Ⅲ and 4.3-
fold of Ⅱ (p < 0.001).  Meanwhile, calculating only the cells with neurites, number 
of neurites per cell in Ⅳ showed statistically significant increase compared with both 
Ⅱ and Ⅲ, resulting in 1.3-fold to Ⅱ and 1.6-fold to Ⅲ (p < 0.001, respectively).  
Therefore, the average number of neurites per cell was highest in both total cells and 
cells sprouting neurites in Ⅳ compared to the other experimental groups.  And the 
100 
 
difference in the number of neurites of total cells and of the cells sprouting neurites 





6.3.3 Length of neurites per cell 
In 4 experimental groups, not only the number of neurites per cell which was 
described above, but also the length of the neurites was analyzed.  As the analysis 
of average neurite numbers, 150 cells for each experimental groups were used to 
measure the length of neurites.  The length of all the neurites sprouted from each 
cell was measured one by one and the following values were calculated (Figure 
6.3.3.1); the length of primary neurites (which were the longest in each cell), sum of 
the length of primary neurites and secondary neurites (which were second longest in 
each cell), and sum of the length of total neurites extending from one cell. 
According to the analysis, the length of primary neurite, secondary neurite, and 
the total neurites were all zero in the control group, undifferentiated hESCs (I), since 
neurites were not observed in any of the cells in I. 
In 2D hESCs neurally induced using NIM (Ⅱ), the mean length of the primary 
neurites was 31.57 μm.  And in Ⅲ, the 2D hESCs neurally induced using NIM and 
the MNPs, the mean length of the primary neurites was 53.68 μm, which was 1.7-
fold of Ⅱ.  The mean value of the primary neurite length in the experimental group 
Ⅳ, the hEBs which were neurally induced with NIM, was 57.27 μm, 1.8-fold of Ⅱ.  
As a result, the length of primary neurites in experimental group Ⅲ and Ⅳ increased 
statistically significantly compared to Ⅱ (p < 0.001). 
The sum of length of the primary and secondary neurites in one cell was calculated 
and then compared among the experimental groups.  The mean length of this value 






Figure 6.3.3.1  Length of the neurites per cell.  The length of primary neurites, 
sum of primary and secondary neurites, and total neurites was investigated.  The 
mean value of each length was highest in the experimental group Ⅳ, compared to 




111.00 μm in Ⅳ, nearly twice of Ⅱ.  As a result, the sum of the primary neurite and 
secondary neurite length in the experimental group Ⅲ and Ⅳ remarkably increased 
compared to the group Ⅱ (p < 0.001). 
Finally, the sum of length of the total neurites sprouted from one cell was 
calculated and the investigated between the experimental groups.  In Ⅱ, the mean 
value of total neurite length was 69.14 μm.  On the other hand, in Ⅲ 131.76 μm 
and in Ⅳ 149.51 μm, which were 1.9-fold and 2.2-fold compared with the group Ⅱ, 
respectively.  In conclusion, the length of total neurites in the experimental group 
Ⅲ and Ⅳ was statistically enlarged when compared to Ⅱ (p < 0.001). 
From the experimental group I to Ⅳ, the length of the primary neurite, sum of 
primary and secondary neurites, and total neurites increased, respectively.  In 
addition, the subtract between the length of total neurites and the length of primary 





6.4 Immunocytochemical analysis (ICC) 
6.4.1 ICC of pluripotency markers 
To compare and analyze the neural induction in 4 experimental groups, expression 
of several related proteins was investigated through immunocytochemical analysis 
(ICC).  The representative markers for ICC were described with their related 
functions in Table 6.3.  First, the expression of the pluripotency, which is a unique 
property of the hESCs, was detected by representative pluripotency markers, and 
then whether or not the differentiation occurred was verified.  As the representative 
pluripotency marker proteins, NANOG and sex determining region Y-box 2 (SOX2) 
were used.  On the other hand, the neural induction markers used were as follows; 
glial fibrillary acidic protein (GFAP), indicating the growth of intermediate filament 
and the maintenance of cell shape; paired box 6 (PAX6), indicating the development 
of brain during embryogenesis; and prospero homeobox protein 1 (PROX1), 
indicating the development of white matter of the brain during embryogenesis 
process. 
First, the expression of pluripotency markers was investigated via fluorescence 
images obtained from ICC.  In Figure 6.4.1.1, the nuclei of the cells were labeled 
as blue fluorescence, and NANOG was labeled with green fluorescence.  In the 
control group, the pluripotent hESCs (I), NANOG expression was clearly observed, 
while there was not any expression of NANOG in the other groups.  And the nuclei 
shown as blue in I represented the cells in colonies and the nuclei in Ⅳ indicated 

















Figure 6.4.1.1  ICC of pluripotency marker NANOG.  The nuclei were 
represented as blue and a pluripotency marker protein NANOG was shown as green 
in 4 experimental groups.  Only in the control group, undifferentiated hESCs, 








Figure 6.4.1.2  ICC of pluripotency marker SOX2.  The nuclei were represented 
as blue and a pluripotency marker protein SOX2 was shown as green in 4 
experimental groups.  Only in the control group, undifferentiated hESCs, SOX2 





control group showed obvious green fluorescence which indicating SOX2, different 
from the other groups.  As a result, the hESCs remained pluripotent only in the 
control group, and the cells existed in the form of colonies, when confirmed by blue 
fluorescence.  On the other hand, the hESCs lost pluripotency due to the 
differentiation in experimental group Ⅱ, Ⅲ and Ⅳ, and the intercellular distance was 
enlarged, resulting in loss of the colony form. 
The fluorescence in the images above was quantified depending on the intensity 
and then the calculated values were compared among the experimental groups 
(Figure 6.4.1.3).  The expression level of pluripotency markers was quantitated on 
the basis of the control group, the undifferentiated hESCs (I), which showed the 
maximum expression of the pluripotency markers compared to the other 
experimental groups.  When the relative fluorescent intensity of the control group 
was 100%, the values of the other groups were statistically significantly lower, 
resulting in under the 0.5%, in the comparison of the expression level of NANOG (p 
< 0.001).  Likewise, the expression level of SOX2 was significantly reduced in 
experimental group Ⅱ, Ⅲ and Ⅳ, resulting in 0.5%, 0.4% and 0.4% respectively, 
compared with the control group, in which the relative fluorescent intensity was 100% 
(p < 0.001).  In conclusion, the expression of both NANOG and SOX2, the 
representative pluripotency markers, was significantly decreased in Ⅱ, Ⅲ and Ⅳ 
different from I, as shown in the ICC images above.  Therefore, the pluripotency of 
the control group, as well as the differentiation of the other experimental groups 




Figure 6.4.1.3  Quantified fluorescent intensity of pluripotency markers.  The 
expression level of the pluripotency markers was quantified relative to the control 
group (100%), which showed maximum expression in both NANOG (A) and SOX2 
(B).  The relative expression of NANOG and SOX2 in group Ⅱ, Ⅲ and Ⅳ was 




6.4.2 ICC of neural induction markers 
The expression of neural induction markers was investigated via fluorescence 
images obtained from ICC, as the expression of pluripotency markers described 
above. 
In Figure 6.4.2.1, the nuclei of the cells were labeled as blue fluorescence, and 
GFAP was labeled with red fluorescence.  In the control group, the undifferentiated 
hESCs (I), nuclei were observed as blue in the form of cell colonies, while GFAP 
expression was not observed at all.  Similarly, in the experimental group Ⅱ, 
conventionally differentiated hESCs with NIM, only the nuclei were shown as blue, 
but there was not any expression of GFAP.  On the other hand, both in the hESCs 
neurally induced with NIM and the MNPs (Ⅲ), and the neurally induced hEBs (Ⅳ), 
the GFAP was expressed as red.  And the expression of the red fluorescence 
representing GFAP was remarkably enhanced in the experimental group Ⅳ, 
compared with Ⅲ. 
The expression of another neural induction marker, PAX6, was investigated as 
shown in Figure 6.4.2.2.  As mentioned in GFAP expression of the control group, 
the pluripotent hESCs (I) did not show any red fluorescence which indicating PAX6, 
different from the other groups.  However, the experimental group Ⅱ, Ⅲ and Ⅳ 
showed obvious PAX6 expression through red fluorescence.  In the group Ⅱ than I, 
also in group Ⅲ compared to Ⅱ, and in the last group Ⅳ than Ⅲ, red fluorescence 
was enhanced, and thus intensity of the purple fluorescence in merged image also 







Figure 6.4.2.1  ICC of neural induction marker GFAP.  The nuclei were 
represented as blue and a neural induction marker protein GFAP was shown as red 
in 4 experimental groups.  Contrary to the control group and group Ⅱ, GFAP was 








Figure 6.4.2.2  ICC of neural induction marker PAX6.  The nuclei were 
represented as blue and a neural induction marker protein PAX6 was shown as red 
in 4 experimental groups.  Contrary to the control group, PAX6 was expressed in 
the experimental group Ⅱ, Ⅲ and Ⅳ.  And compared with the other groups, the 




of the cells was elongated linear, and the neurites extended from each cell seemed to 
connect the cells with other cells. 
Finally, the expression of the last neural induction marker, PROX1, was observed 
in Figure 6.4.2.3.  In the control group and the group Ⅱ, red fluorescence 
representing PROX1 was not observed.  Only nuclei were observed as blue in the 
form of cellular colonies in I, and in both compact cellular colony-like forms and 
distanced cells in Ⅱ, respectively.  Meanwhile, PROX1 was expressed as red in the 
hESCs differentiated with NIM and the MNPs (Ⅲ), and also in neurally induced 
hEBs (Ⅳ). 
As a result, the undifferentiated hESCs did not show neural induction at all, and 
remained pluripotent in the form of cellular colonies.  On the other hand, the hESCs 
lost pluripotency and neurally induced in experimental group Ⅱ, Ⅲ and Ⅳ, and the 
differentiation degree, represented as red fluorescence of neural induction markers, 
increased toward the end group. 
The fluorescence in the images obtained was quantified depending on the intensity 
and then the calculated values were compared among the experimental groups 
(Figure 6.4.2.4).  The expression level of neural induction markers was quantitated 
on the basis of the last group, neurally induced hEBs (Ⅳ), which showed the 
maximum expression of the neural induction markers compared to the other 
experimental groups. 
In the comparison of the expression level of GFAP, the values of the control group 







Figure 6.4.2.3  ICC of neural induction marker PROX1.  The nuclei were 
represented as blue and a neural induction marker protein PROX1 was shown as red 
in 4 experimental groups.  Contrary to the control group and the group Ⅱ, PROX1 







Figure 6.4.2.4  Quantified fluorescent intensity of the neural induction markers.  The expression level of the neural induction markers was 
quantified relative to the group Ⅳ (100%), which showed maximum expression in GFAP (A), PAX6 (B) and PROX1 (C).  The relative expression 
of GFAP, PAX6 and PROX1 in group Ⅳ was statistically up-regulated compared with the other groups.  *** indicated p < 0.001.  
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Ⅳ was 100% and the value of group Ⅲ was 19.8%.  Thus, the quantitative GFAP 
expression in the control group and Ⅱ did not show any statistical significance, while 
the expression in Ⅲ was significantly enhanced compared to both I and Ⅱ (p < 0.001, 
respectively).  Furthermore, the expression of GFAP in Ⅳ increased statistically 
compared with the other groups (p < 0.001, respectively), resulting in more than 5.0-
fold to Ⅲ. 
Regarding the expression of PAX6, the quantified value of the control group was 
under 1.0%, value of the group Ⅱ was 33.9%, and the value of the Ⅲ was 73.7%, 
respectively.  Thus, the expression level of PAX6 was statistically enhanced toward 
the end group.  The level of Ⅱ was significantly increased compared with the 
control group (p < 0.001), and the value of Ⅲ, which was 2.2-fold of Ⅱ, was 
statistically increased than the group Ⅱ (p < 0.001).  Moreover, the PAX6 
expression level of Ⅳ was significantly improved when compared to the group Ⅲ, 
resulting in 1.4-fold to Ⅲ (p < 0.001). 
In the analysis of the PROX1 expression, the control group showed the value 
under 1.0%, as the other neural induction marker proteins in group I.  However, in 
the group Ⅱ, the expression level of PROX1 was 6.1%, and in Ⅲ, it was 23.5%.  
The statistical significance was similar to the expression of PAX6.  The value of 
the experimental group Ⅱ was statistically enhanced compared with the control group 
(p < 0.001), and the expression in Ⅲ was significantly increased than Ⅱ, resulting in 
3.9-fold of the group Ⅱ (p < 0.001).  Furthermore, the expression level in Ⅳ, which 
was 4.3-fold to Ⅲ, was statistically emhanced compared with Ⅲ (p < 0.001). 
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In conclusion, the expression of neural induction markers, GFAP, PAX6 and 






6.5 Genetical analysis 
To investigate neural induction in 4 experimental groups, genetic analysis was 
performed to measure the expressed mRNA levels according to the expression of 
related genes.  Each of the expressed genes was normalized by glyceraldehyde 3-
phosphate dehydrogenase (GAPDH), an endogenous reference gene, and then they 
were analyzed using relative quantification methods.  All the data were compared 
with each value of the control group, the undifferentiated hESCs (I), which was 
marked as 1 for the relative fold induction (RFI).  As a pluripotency marker gene, 
octamer-binding transcription factor 4 (OCT4) was utilized, and neural induction 
marker genes used were as follows; growth associated protein 43 (GAP43), related 
to the neuronal growth and the neurite formation; β3-tubulin (TUBB3), indicating 
microtubule formation; nestin (NES), related to the intermediate filament growth and 
the axon growth; and GFAP, indicating the intermediate filament growth and the 
cellular shape maintenance.  The primer sequences of each gene for real time RT-
PCR were listed in Table 6.4. 
According to the Figure 6.5.1, the expression of OCT4, a pluripotency marker, 
was statistically decreased in experimental group Ⅱ, Ⅲ and Ⅳ, resulting in 0.6, 0.3 
and 0.2 respectively, compared to the control group in which the RFI value was 1 (p 
< 0.001).  And a neural induction marker, GAP43, was significantly increased in Ⅱ, 
Ⅲ and Ⅳ, compared with the control group I (p < 0.001).  In the expression of NES 















Figure 6.5.1  Genetical analysis of a pluripotency marker and neural induction markers.  The expression of all the genes was normalized by 
each value of the control group.  The relative expression of the neural induction marker genes increased in group Ⅱ, Ⅲ and Ⅳ compared with 
the control group.  *** indicates p < 0.001.
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the control group, while in Ⅲ and Ⅳ, their expression significantly increased (p < 
0.001). 
For more detailed comparisons between the experimental groups, the graphs were 
divided and then analyzed depending on each gene (Figure 6.5.2).  According to 
the comparison of the GAP43 expression (Figure 6.5.2 A), there was a statistically 
significant increase in experimental group Ⅱ compared to the control group, also in 
group Ⅲ compared to Ⅱ, and in the last group, Ⅳ compared with Ⅲ (p < 0.001, 
respectively).  The relative value of the expression in Ⅱ was 3.0, which was 3.0-
fold of the control group, and in Ⅲ was 5.4, which was 1.8-fold to Ⅱ.  Moreover, 
the RFI of Ⅳ was 11.2, which was 3.7-fold of Ⅱ, and 2.1-fold to Ⅲ, respectively.  
Thus, the expression of GAP43 was most prominent in the last group (Ⅳ). 
In the comparison of NES and GFAP expression through Figure 6.5.2 C and D 
respectively, there was no significant difference between the control group and the 
experimental group Ⅱ.  The relative value of Ⅱ was 1.5 in both NES and GFAP 
expression.  On the other hand, the expression of both genes was significantly 
increased in Ⅲ compared to Ⅱ, and in Ⅳ compared with Ⅲ (p < 0.001, respectively).  
In the expression of NES, the RFI of Ⅲ was 23.6, which was 15.7-fold of Ⅱ, and the 
value of Ⅳ was 158.3, which was 105.5-fold to Ⅱ and 6.7-fold of Ⅲ, respectively.  
Meanwhile, in GFAP expression the RFI value of Ⅲ was 5.2, which was 3.5-fold of 









Figure 6.5.2  Comparison of neural induction marker expression through genetical 
analysis.  The relative expression of the neural induction markers, GAP43 (A), 
TUBB3 (B), NES (C) and GFAP (D), was compared between the experimental groups.  
The expression of GAP43, NES and GFAP, showed statistically significant increase 




Therefore, the expression of these three genes resulted in significant neural 
induction of the hESCs differentiated with NIM and the MNPs (Ⅲ) and also neurally 
induced hEBs (Ⅳ), contrary to the undifferentiated hESCs (I) and conventionally 
differentiated hESCs with NIM (Ⅱ). 
However, when the expression level of TUBB3 was compared, a slightly different 
tendency was observed (Figure 6.5.2 B).  Although the standard deviation of the 
experimental group Ⅲ was quite large, it was confirmed that TUBB3 expression level 
in Ⅱ and Ⅲ was higher than that of group Ⅳ.  The relative value in Ⅳ was 5.4, the 
RFI in Ⅱ was 15.0, which was 2.8-fold of Ⅳ, and the value in Ⅲ was 8.1, 1.5-fold 
to Ⅳ.  This was a very specific phenomenon as compared to the expression pattern 
of the other neural induction markers, increasing toward the end group (Ⅳ) as 
described above.  That is to say, the expression of TUBB3 was down-regulated in 
the experimental group Ⅳ, a 3D cell culture and differentiation, when compared 





The small-sized hEBs (150 μm in diameter), generated by the MNPs and the 
concentrated magnetic force system, were spontaneously differentiated into 
ectodermal lineage in hEB culture medium for 3 days, and some of those cells 
showed neurite-like outgrowth.  So, I decided to improve the neural induction of 
the hESCs in the form of the small-sized hEBs replacing the hEB culture medium to 
NIM, and increasing the duration for differentiation from 3 days to 5 days.  To 
investigate the improvement of the neural induction of the small-sized hEBs (Ⅳ), 
comparable groups were set as follows; undifferentiated hESCs (Ⅰ), conventionally 
differentiated hESCs with NIM (Ⅱ), and conventionally differentiated hESCs with 
NIM and MNPs (Ⅲ). 
To detect the neural induction of 4 experimental groups, the superficial 
morphology of the cells was observed.  The intrinsic shape of natural hESCs was 
small (less than 10 μm in diameter) and round, in the form of cellular colonies.  
According to the morphological analysis, neurally induced hESCs in group Ⅱ, Ⅲ and 
Ⅳ were changed in their appearance, resulting in formation of tiny projections on 
cells, called neurites.  Therefore, the neurally induced hESCs became sharp-
pointed, and the compact colonies were disrupted, producing enough intercellular 
distance between cells. 
The hESCs were divided by number of neurites per cell; cells without any neurites, 
cells with one neurite, cells with 2 neurites, and the cells with 3 or more neurites.  
And then the proportion of each type was investigated.  In the control group, 
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undifferentiated hESCs (Ⅰ), all of the cells existed without neurite, and in group Ⅱ 
more than half of the cells existed without neurites.  However, in both Ⅲ and Ⅳ, 
about 90% of the cells existed with neurites, and the hESCs with 3 or more neurites 
per cell were more than 30%, respectively.  And the average number of the neurites 
per cell was also calculated.  In total cells, including the cells without neurites, 
number of neurites was 0 in the control group, 0.45 in Ⅱ, 1.31 in Ⅲ, and 1.94 in 
group Ⅳ.  Meanwhile, in only the cells sprouting neurites, the number of neurites 
per cell was 0 in the control group, 1.90 in Ⅱ, 1.54 in Ⅲ, and 2.50 in Ⅳ.  Both the 
number of neurites per cell in total cells and in the cells with neurites increased 
toward the end group (Ⅳ). 
Also the length of all the neurites sprouted from each cell was measured one by 
one, and the following values were calculated; the length of primary neurites (which 
were the longest in each cell), sum of the length of primary neurites and secondary 
neurites (which were second longest in each cell), and sum of the length of total 
neurites extending from one cell.  From the experimental group I to Ⅳ, the length 
of the primary neurite, sum of primary and secondary neurites, and total neurites 
increased, respectively.  In addition, the difference between the total neurite length 
and the length of primary neurites enhanced toward the end group, either. 
According to ICC and the quantification of fluorescent intensity, only the control 
group, undifferentiated hESCs (Ⅰ), possess pluripotency, whereas the other groups 
did not show any expressions of pluripotency markers, represented as NANOG and 
SOX2.  On the other hand, the expression of neural induction markers, represented 
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as GFAP, PAX6, and PROX1, was detected in the experimental group Ⅱ, Ⅲ and Ⅳ, 
contrary to the control group.  And the expression level of those neural induction 
marker proteins significantly increased toward the end group. 
According to genetical analysis, the expression of a pluripotency marker gene, 
OCT4, significantly decreased in the experimental group Ⅱ, Ⅲ and Ⅳ, compared 
with the control group.  However, the expression of neural marker genes, 
represented as GAP43, NES and GFAP, showed statistically significant increase in 
Ⅳ compared to the other groups.  Among the neural induction marker genes, only 
the TUBB3 showed different result; its expression was reduced in Ⅳ compared to 
the group Ⅱ and Ⅲ. 
In conclusion, the hEBs in NIM for 5 days were successfully differentiated, 
resulting in the improvement of the hESC neural induction and the acceleration of 
initial neural differentiation.  The time required for initial neural induction and 
neurite outgrowth was reduced from 2 to 3 weeks to 5 days, compared with previous 
work [122].  And this improved neural inductivity was statistically confirmed 
through morphological analysis, ICC and genetical analysis, comparing with the 
undifferentiated hESCs, conventionally differentiated hESCs with NIM, and 








Mechanisms of accelerated 
neural induction of small-sized 
human embryoid bodies   
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Chapter 7. Mechanisms of accelerated neural induction of 
small-sized human embryoid bodies (hEBs) 
7.1 Introduction  
In the previous chapter, the neural induction of human embryonic stem cells 
(hESCs) was investigated and compared in 4 experimental groups.  According to 
the results (Figure 7.1.1), the neural induction was improved in the group Ⅱ, in which 
the culture medium of the undifferentiated hESCs (Ⅰ) was changed to neural 
induction medium (NIM).  Furthermore, neural induction was more enhanced when 
the magnetic nanoparticles (MNPs) were treated with NIM (Ⅲ), compared with 
group Ⅱ.  And when the hESCs gathered by the concentrated magnetic force system 
and then formed the human embryoid bodies (hEBs) (Ⅳ), three-dimensional (3D) 
cell aggregates, with NIM and the MNPs, the neural differentiation was most 
accelerated, compared with the other groups.  The differentiation patterns were 
investigated statistically through morphological analysis, related protein analysis 
and the representative gene analysis.  In other words, it was confirmed that the 
neural differentiation was improved from the control group to the experimental 
groups Ⅱ, Ⅲ, and Ⅳ. 
In this chapter, in order to analyze these phenomenon, the related signaling 
pathways which happen inside the cells, leading particular cell fate, were identified.  








Figure 7.1.1  Schematics for accelerated neural induction.  The neural induction 
of small-sized hEBs (Ⅳ) was most accelerated compared to the other groups.  From 
the undifferentiated hESCs (Ⅰ) to the experimental group Ⅱ, Ⅲ and Ⅳ, the neural 









7.2 WNT signaling pathways 
WNT proteins encoded by WNT genes, which express various types of cystein-
rich glycoproteins, regulate various behaviors of the cells, represented as cell death, 
carcinogenesis, migration and cell differentiation [131-133].  According to former 
studies, among WNT family proteins, WNT3 and WNT5α possess important effects 
on the regulation of cell fate during embryological development (Figure 7.2.1) [134-
139].  That is to say, those proteins are necessary for the differentiation of the 
hESCs.  The activation of WNT3 proteins results in differentiation of pluripotent 
stem cells (PSCs) into neural progenitor cells (NPCs), and then differentiation of the 
NPCs into mature neurons [134-136].  Moreover, the WNT3 has known to be 
concerned with the conversion of non-neuronal nerve cells, such as glial cells, into 
neuron-like cells.  Meanwhile, the expression of WNT5α has known to be lead to 
induction of PSCs into NPCs, and the differentiation of the NPCs into neurons and 
glial cells [137-139]. 
Based on this, in order to verify the activated signaling pathways during neural 
induction of the hESCs, I investigated these WNT3 and WNT5α expression in 4 
experimental groups through Western blotting (Figure 7.2.2).  When β-actin was 
used as a reference protein, which is expressed constantly in all groups, the 
expression of WNT3 and WNT5α was analyzed and compared.  The expressed 
WNT3 was remarkably observed in group Ⅳ, when compared with the other groups.  
WNT5α was expressed only in group Ⅱ.  In group Ⅲ, the hESCs were neurally 






Figure 7.2.1  Schematics for WNT signaling pathways.  Both WNT3 and WNT5α 









Figure 7.2.2  Western blotting of WNT proteins.  As a reference protein, β-actin 
was used.  WNT3 was expressed only in the experimental group Ⅳ compared with 
the other groups.  On the other hand, WNT5α was expressed only in group Ⅱ 




experimental group Ⅲ is related to the group Ⅱ in terms of NIM use, and also related 
to the group Ⅳ in terms of MNP application.  In addition, according to the results 
of chapter 6, neural differentiation of group Ⅲ was verified, like group Ⅱ and Ⅳ.  
However, according to Figure 7.2.2, neural induction in group Ⅲ seems to follow 
other signaling pathways different from WNT3 and WNT5a.  Accordingly, the 
accelerated neural induction of the hESCs in Ⅳ was considered to follow WNT3 





7.3 Dopaminergic neuronal pathways 
7.3.1 Expression of glial cell line-derived neurotrophic growth 
factor (GDNF) 
Among the various neuronal factors, one of the most important is glial cell line-
derived neurotrophic growth factor (GDNF), which is a distantly related member of 
the transforming growth factor-β (TGF-β) superfamily [140, 141].  Therefore, it is 
a kind of multifunctional cytokine regulating pathway proteins by activating various 
downstream substrates in signaling cascades.  The GDNF is expressed in a dynamic 
pattern in the anterior neuroectoderm during early stages of neurogenesis [142-148].  
Significant roles of the GDNF are to promote the survival and development of the 
neurons which have high affinity with dopamine (Figure 7.3.1.1) [145, 146].  Thus, 
the GDNF prevents apoptosis of motor neurons and improves differentiation of 
dopaminergic neurons. 
In order to detect the dopaminergic neuronal pathways in the experimental groups, 
the expression of GDNF was observed through immunocytochemical analysis (ICC) 
in neurally induced hESCs (Figure 7.3.1.2).  Because the experimental group Ⅱ 
(conventionally differentiated hESCs with NIM), group Ⅲ (neurally induced hESCs 
with NIM and MNPs), and the group Ⅳ (neurally induced hEBs with NIM and 
MNPs) were neurally differentiated, GDNF expression in these three groups was 
investigated.  The nuclei were shown as blue fluorescence in group Ⅱ, Ⅲ and Ⅳ, 












Figure 7.3.1.2  GDNF expression.  (A) The expression of dopaminergic neuronal pathway protein, GDNF was investigated through ICC.  
Nuclei were observed as blue and GDNF was shown as red.  Scale bars indicate 200 μm.  (B) The fluorescent intensity of GDNF was quantified.  
N.S. indicated not significant, and *** indicated p < 0.001. 
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and Ⅲ, the expression of red fluorescence, representing GDNF, was remarkably 
observed in group Ⅳ.  And the morphology of the cells in Ⅳ was linear and 
sharpen with neurites sprouted from the cell body.  The fluorescence in the images 
was quantified depending on the intensity and then calculated values were compared 
among the experimental groups (Figure 7.3.1.2 B).  The expression level of GDNF 
was quantitated relative to group Ⅳ, which showed the maximum expression of 
GDNF compared to the other experimental groups.  When the relative fluorescent 
intensity of group Ⅳ was 100%, the values of group Ⅱ and Ⅲ were statistically 
significantly lower (p < 0.001), while there was no significant difference in the 
values between group Ⅱ and Ⅲ. 
According to the results, the hESCs in the form of small-sized hEBs with NIM 
and MNPs (Ⅳ) were neurally differentiated expressing GDNF, different from other 
groups.  Therefore, some of the neurally induced hESCs in group Ⅳ were 
considered to possess affinity with dopamine.  However, the dopamine-related 
function of mature neurons and dopaminergic signaling pathway should be verified 





7.4 Intracellular communications 
7.4.1 Expression of neural cell adhesion molecule (NCAM) 
There are several groups of the cell adhesion molecules which mediate cell-to-cell 
and cell to extracellular matrix (ECM) interactions; the immunoglobulin superfamily, 
the cadherin family, the integrin superfamily, the selection family and the epidermal 
growth factor family [149, 150].  Among those cell adhesion molecules, the neural 
cell adhesion molecule (NCAM), a member of the immunoglobulin superfamily, is 
responsible for not only neural cell adhesion and recognition but also the neural 
development (Figure 7.4.1.1) [151, 152].  The NCAM is a cell surface glycoprotein 
which mediates adhesions and then interactions between the neuron to neuron, 
neuron to glial cell, and neuron to ECM.  And NCAM is highly expressed during 
the developmental processes of the nervous system.  Furthermore, according to the 
related studies, the significant role of NCAM in the central nervous system is 
associated with not only neural development, but also with adult functions, such as 
the processing system of sensory information and neuronal plasticity [151-156].  
Regarding the effect of NCAM on neurite outgrowth, it has been proposed that 
improvement of the neurite outgrowth occurs above the threshold value of the 
NCAM expression. 
To detect cell adhesions and intercellular communications, the expression of 
NCAM was investigated through ICC in neurally induced hESCs (Figure 7.4.1.2).  












Figure 7.4.1.2  NCAM expression.  (A) The expression of intercellular communication protein, NCAM was investigated through ICC.  Nuclei 
were observed as blue and NCAM was shown as red.  Scale bars indicate 200 μm.  (B) The fluorescent intensity of NCAM was quantified.  
N.S. indicated not significant, and * indicated p < 0.05. 
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which physical condition of cell cultivation was different; two-dimension (2D) in the 
experimental group Ⅱ and Ⅲ, and 3D in the group Ⅳ.  The nuclei were represented 
as blue, NCAM was observed as red, and the merged images showed bright purple 
fluorescence in the group Ⅱ, Ⅲ and Ⅳ (Figure 7.4.1.2 A).  In both group Ⅱ and Ⅲ, 
the hESCs adhered to the bottom of flask in 2D condition expressed NCAM.  In the 
group Ⅳ, though the cells were cultured in suspended condition, in which cell 
adhesion to bottom was inhibited, the expression of NCAM was obviously observed.  
The fluorescence was quantified depending on the intensity and the values were 
calculated relative to group Ⅳ, which showed maximum expression of NCAM 
(Figure 7.4.1.2 B).  When the relative fluorescent intensity of Ⅳ was 100%, the 
values of group Ⅱ was 74.0±7.6%, and group Ⅲ was 84.5±7.9%, respectively.  
There was no statistical significance in NCAM expression between group Ⅱ and Ⅲ, 
and group Ⅲ and Ⅳ, either.  However, NCAM expression of group Ⅳ showed 
statistical improvement compared to group Ⅱ (p < 0.05). 
Accordingly, it was confirmed that the expression of NCAM did not to depend on 
the application of MNPs, when comparing the results of group Ⅱ and Ⅲ.  In 
addition, by comparing the experimental group Ⅲ and Ⅳ, it was evaluated that 
NCAM expression was not impeded when external stimulation derived from 
concentrated magnetic force was applied, even when the cells were cultured in 3D 
condition.  Consequently, the hESCs differentiated in suspended condition (Ⅳ) 
expressed sufficient NCAM when compared with neurally induced hESCs in 2D 
condition (Ⅱ and Ⅲ).  This result indicated that cell-to-cell adhesions and 
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interactions were enhanced in 3D suspended culture condition, though cell to bottom 





7.5.1 Expression of microtubule-associated protein 2 (MAP2) 
To maintain cellular morphology, proteins involved in the cytoskeletons exist 
inside the cells and complex structures are formed from those cytoskeletal proteins 
[66].  There are three categories of the cytoskeletal proteins present throughout the 
cell; microtubules, intermediate filaments, and actin filaments [157, 158].  
Interactions and changes between them enable important cellular actions, such as 
cell contraction, migration and cleavage.  In addition, these cytoskeletal proteins 
act as receptors for external stimuli. 
The microtubule-associated protein 2 (MAP2) is a member of MAP family, which 
is known to be involved in microtubule assembly and neurite genesis [159, 160].  
The MAP2 stabilizes growth of microtubules by crosslinking them with intermediate 
filaments and other microtubules (Figure 7.5.1.1) [161, 162].  Also MAP2 forms 
neuron-specific cytoskeletons, determining and stabilizing the shape of nerve cells 
during neuronal development.  Therefore, MAP2 is a protein that sensitively 
responses to physical stimuli externally applied to cells.  When an external force is 
applied to cells, this stimulation could be transmitted inside the cells by 
cytoskeletons which are mediated by MAP2 [163, 164].  And this process 
facilitates neuronal differentiation through transfer of the mechanical stimuli. 
In this chapter, in order to verify the effect of magnetic force and the 3D 















the proteins related to the mechanotransduction was investigated. 
By observing the expression level of MAP2, microtubule growth and neural 
development promoted through mechanotransduction was analyzed in neurally 
induced hESCs (Figure 7.5.1.2).  The nuclei were represented as blue, MAP2 was 
observed as red, and the merged images showed bright purple fluorescence in the 
experimental group Ⅱ, Ⅲ and Ⅳ (Figure 7.5.1.2 A).  In three experimental groups, 
the expression of MAP2 was observed similarly.  By quantifying the relative 
fluorescent intensity, it was evaluated that there was no statistical significance of 
MAP2 expression among all the groups (Figure 7.5.1.2 B). 
Although the results of microtubule growth and genesis, which were represented 
by red fluorescence seemed not to be different, the circumstances of cell cultivation 
were distinguishable; 2D for group Ⅱ, 2D with MNPs for group Ⅲ, and 3D with 
MNPs and the concentrated magnetic force for the group Ⅳ.  Therefore, the cause 
and process of the microtubule generation would be different in those experimental 
groups.  In group Ⅱ and Ⅲ, the cells adhered to bottom enlarging the contact area 
of cell bodies, thus cytoskeletal proteins such as microtubules were expressed 
sufficiently.  However, in group Ⅳ, the cells were suspended and only cell-to-cell 






Figure 7.5.1.2  MAP2 expression.  (A) The expression of cytoskeleton-related protein, MAP2 was investigated through ICC.  Nuclei were 
observed as blue and MAP2 was shown as red.  Scale bars indicate 200 μm.  (B) The fluorescent intensity of MAP2 was quantified.  N.S. 
indicated not significant. 
148 
 
7.5.2 Expression of focal adhesion kinase (FAK) 
An important question in cell biology is how the receptors in cellular membrane 
transmit extracellular signals inside the cells [165, 166].  Focal adhesion kinase 
(FAK) is a crucial signaling component, which is activated by various stimuli, as a 
biosensor or integrator to modulate cell adhesions and motility.  The activated FAK 
is a highly tyrosine-phophorylated protein involved in the cytoskeletons, structures 
of cell adhesion sites, called focal contacts, and membrane protrusions (Figure 
7.5.2.1) [167].  FAK pays a key role at early steps in reception of mechanical 
stimulation outside the cells [167, 168].  Through the FAK activation, intracellular 
signal transduction pathways could be turned on.  Thus, the activated form of FAK 
is necessary during the stem cell development, for recognizing the exterior physical 
factors. 
In order to detect the mechanical stimuli-induced neural differentiation of the 
hESCs, the expression of FAK in neurally induced hESCs was estimated (Figure 
7.5.2.2).  The nuclei were shown as blue and FAK was detected by red fluorescence 
(Figure 7.5.2.2 A).  All the neurally induced hESCs in the experimental group Ⅱ to 
Ⅳ expressed the FAK.  According to the quantitated results, there was no 
significant differences of FAK expression between the group Ⅱ and Ⅲ, between 
group Ⅲ and Ⅳ, and also between Ⅱ and Ⅳ (Figure 7.5.2.2 B).  Although the 
hESCs in group Ⅳ were cultivated in suspended condition, in which cell adhesion 
to bottom was hindered, the cells expressed sufficient FAK, compared with group Ⅱ 














Figure 7.5.2.2  FAK expression.  (A) The expression of mechanotransduction protein, FAK was investigated through ICC.  Nuclei were 




Therefore, it was verified that the neurally differentiated hESCs in the 
experimental group Ⅳ underwent focal adhesion stimuli in suspended condition, like 
adhesive cells did.  And this physical stimulation, which was detected and then 
transmitted intracellularly by FAK, is considered to result from the concentrated 





In previous chapter, the accelerated neural induction of the small-sized hEBs was 
investigated.  So, in order to find the cause of this result, several signaling pathways, 
which were considered to be related, were analyzed. 
First, WNT signaling pathways were investigated through Western blotting of 
WNT3 and WNT5α proteins in 4 experimental groups.  According to the 
immunoblotting, the accelerated neural induction of small-sized hEBs (Ⅳ) followed 
WNT3 signaling pathway rather than WNT5α pathway.  On the other hand, the 
neurally induced hESCs using conventional method (Ⅱ) followed the WNT5α 
signaling pathway. 
According to the expression of GDNF in neurally induced hESCs (group Ⅱ to Ⅳ), 
GDNF expression was remarkably enhanced in group Ⅳ, compared with group Ⅱ 
and Ⅲ.  It was evaluated that some of the neurally differentiated hESCs in Ⅳ 
possess affinity with dopamine, different from the group Ⅱ and Ⅲ. 
And the NCAM expression, which was not significant between group Ⅱ and Ⅲ, 
and also between group Ⅱ and Ⅳ, indicated that cell-to-cell adhesions and 
interactions were improved in the hESCs differentiated in 3D suspended condition 
(Ⅳ), in which cell adhesion to bottom was prohibited. 
Regarding the MAP2 expression, there was no statistical difference among all the 
neurally induced groups.  In group Ⅳ, cytoskeletons were generated and organized 
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like in group Ⅱ and Ⅲ, adhesive condition.  Enhanced cell-to-cell communications 
were considered to induce those microtubule growth and genesis. 
The expression of FAK was not different among the groups, either.  It indicated 
that the neurally induced hESCs in suspended condition (Ⅳ) underwent focal 
adhesive stimuli like the cells in group Ⅱ and Ⅲ did. 
As a result, the accelerated neural induction of the small-sized hEBs (Ⅳ) followed 
WNT3 signaling pathway and some possessed dopamine-affinity, represented as the 
expression of GDNF.  Those results were considered to result from the enhanced 
cell-to-cell adhesions and interactions, which were indicated by NCAM expression, 
and also from the concentrated magnetic force-derived mechanical stimuli, which 









and further suggestions  
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Chapter 8. Overall discussion and further suggestions 
Human embryonic stem cells (hESCs) have been used in tissue engineering and 
regenerative medicine due to their ability to differentiate into various cell types [1-
7].  The use of hESCs in such studies requires precise control over differentiation 
of the hESCs into specific types of cells [10-14].  Recently, researchers have 
focused on novel methods to selectively differentiate the hESCs via physical factors, 
contrary to conventional differentiation depending on chemical factors [21-23].  
Accordingly, the generation of the human embryoid bodies (hEBs), three-
dimensional (3D) cell aggregates of the hESCs morphologically mimicking embryos, 
has been suggested as an ideal method for efficient differentiation [15, 24-27].  
Furthermore, the effect of the initial hEB size on early lineage specification of the 
hESCs has been extensively studied [109-113]. 
In this thesis, I hypothesized that the size of hEBs is an important mechanical cue 
to direct the fate of the hESCs.  As embryological development proceeds, the 
volume and mass of the cell aggregates are enlarged with increase in the cell amount 
[169, 170].  From this point of view, I could imitate the specific stage of gastrulation 
by regulating the size of the hEBs.  The initial stage of gastrulation, which forms 
the ectoderm, could be mimicked by generating small hEBs, whereas the latter stage 
of gastrulation forming the endoderm and mesoderm could be imitated by a large 
hEB generation. 
I considered a diameter of 300 μm for the hEB as a reference point, as reported in 
previous works [110, 111].  The related studies indicated that hEBs smaller than 
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300 μm in diameter exhibit enhanced dermal or neural differentiation, while hEBs 
larger than 300 μm exhibited enhanced myocardial differentiation.  Thus, the hESC 
commitment was controlled by adjusting the size of the hEBs to be smaller or larger 
than the standard of 300 μm.  The uniformly size-controlled hEBs were efficiently 
generated using the magnetic nanoparticles (MNPs) and the concentrated magnetic 
force system, by regulating the number of cells added in a well.  1×104 cells were 
added for small hEBs with a diameter of 150 μm, and 16×104 cells were added per 
well for large hEBs with a diameter of 600 μm.  In contrast with previous studies, 
the hEBs were induced to differentiate in hEB culture medium without any chemical 
inducers, which are regarded as vital for stem cell differentiation.  By excluding 
other complex factors influencing the hESC differentiation, I could investigate the 
practical effect of the hEB size itself on the early hESC lineage decision. 
In chapter 4, during the experimental process, the MNPs were directly applied to 
the hESCs for intracellular incorporation without any superficial modifications [23, 
171].  The MNPs are covered with lipid layers, which contribute to endocytosis, 
originating from magnetic bacteria, and they showed no significant cytotoxicity to 
the hESCs over all concentrations (up to 50 μg/ml).  However, there was a 
statistically proven cell death in human mesenchymal stem cells (hMSCs) with 
highly concentrated MNPs (higher than 30 μg/ml).  The difference in the cell 
viability with identical MNPs was attributed to the different rate of intracellular 
incorporation according to the cell types.  Unlike other types of stem cells, 
represented as hMSCs and mouse embryonic stem cells (mESCs), the hESCs showed 
a low MNP incorporation because the single cell size of the hESCs is much smaller 
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than that of the others, and the nuclei may account for a large portion of the total area 
of the cells, resulting in a hindrance to the MNP incorporation in cytosol.  As a 
result, the poor efficiency of the MNP incorporation led to not only low cytotoxicity, 
but also improved cell proliferation, even at high concentrations of MNPs in the 
hESCs.  Some related studies have reported that the intracellular metabolism of the 
iron ion would influence cell proliferation signals at limited range of MNP 
concentrations [172-176], and such studies can explain the extremely low 
cytotoxicity and increased cell number of the hESCs, even at high concentrations of 
the MNPs. 
Highly magnetized hESCs were required for use in this concentrated magnetic 
force system because successful hEB generation depends on the magnetization of 
the cells interacting with the magnetic forces at the pinpoints.  To improve the 
accumulation efficiency of the MNPs in cytosols, I applied a feeder-free system in 
the last step of the hESC cultivation.  Conventionally, the hESCs were cultured with 
feeder cells on gelatin-coated tissue culture dishes in hESC growth medium and 
could keep their pluripotency [9].  However, recent studies on stem cells have 
shown that feeder-free cultivation methods of hESCs with various dish coating 
materials, such as Geltrex™, are an alternative technique without side effects on the 
intrinsic characteristics of the pluripotent hESCs [107].  When cultured with feeder 
cells, the hESC colonies were compactly constructed, and the tight cell-to-cell 
contact diminished the cytosolic volume of the single cells, resulting in poor 
accumulation of the MNPs in cytosols.  On the other hand, the hESC colonies were 
loosely woven when cultured without feeders, and hence, the MNPs were efficiently 
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accumulated in hESC cytosols.  Thus, the highly magnetized hESCs could be 
obtained by utilizing a feeder-free culture system during the MNP treatment of the 
hESCs. 
In the spheroid generation using hMSCs and mESCs, 3D cell aggregates were 
generated within seconds.  And the resulted spheroids were compactly organized.  
However, the hEB generation consumed more time due to the innate characteristics 
of the hESCs in terms of the vulnerability during self-organization.  When the 
hESCs are separated into single cells, the cell-to-cell interactions diminish, and the 
apoptotic signals begin to accelerate, resulting in failure for the spontaneous hEB 
generation [177, 178].  Thus, the rho-associated protein kinase (ROCK) inhibitor 
can assist in enhancing the intercellular interactions and the agglomeration of single 
hESCs into clusters [179].  In this work, the concentrated magnetic force system 
facilitated the efficient hEB generation diminishing the cell death of the single 
hESCs without the assistance of ROCK inhibitor.  Accordingly, it could be 
regarded as an alternative to conventional hEB generation methods relying on the 
ROCK-inhibitor. 
In chapter 5, it was revealed that the size of the hEBs is a significant parameter 
to direct the hESC commitments, excluding the need for adjusting other factors as 
chemical inducers.  Such chemical factors have been previously regarded as vital 
to differentiate the hESCs into specific cell types of tissues and organs.  In this 
research, I tried to provide the natural environment of embryogenesis to the hESCs, 
thus the exact effect of the initial size of the hEBs on the generation of 3 germ layers 
159 
 
could be determined without any growth factors.  And it was also suggested that 
the exact size obtained from a theoretical basis for each germinal layer was 150 μm 
for ectoderm and 600 μm for endoderm and mesoderm. 
Some of the small-sized hEBs, which were spontaneously differentiated into 
ectodermal lineage in hEB medium, showed neurite-like outgrowth.  So, in 
chapter 6, the neural induction of the hESCs in the form of hEBs, generated using 
the MNPs and the concentrated magnetic force system, was performed by replacing 
the hEB medium to neural induction medium (NIM).  According to the former 
studies regarding neurogenesis of the hESCs [122], 3 to 4 weeks were needed to 
produce induced neural progenitor cells from the hESCs.  Then 1 to 2 more weeks 
were required to generate early neuro-ectodermal cells, and 3 more months were 
needed to differentiate the cells to mature neuro-ectodermal cells.  After 1 to 3 more 
weeks, the cells were finally matured to three fundamental neural cells, represented 
as neuronal cells, glial cells and astrocytal cells, with functions.  In this process of 
neurogenesis from hESCs, suspension culture of the cells in the form of 3D cell 
aggregates, called “neurosphere”, was considered to be essential.  It seems to be 
due to the fact that the suspending cell aggregates mimic the physical properties, 
represented as stiffness, of the brain tissue, which is very soft among the body tissues 
[123, 124].  Thus, in my study, it was reasonable to facilitate neural induction of 
the hESCs by generating hEBs, 3D hESC aggregates. 
A marked change in the cell shape observed through the morphological analysis 
was related to the neurites, which are tiny projections on neuronal cells.  And not 
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only the number of neurites per cell but also the length of neurites per cell increased 
in neurally induced hEBs, the experimental group Ⅳ, compared to the other groups. 
I calculated the average number of neurites per cell in two different cases; 
calculating the average number of neurites of the total cells, including the cells 
without neurites; calculating the number of neurites of only the cells with neurites.  
The calculated values in two cases were quite different, and the gaps were variant 
depending the experimental groups.  In group Ⅱ, neurally induced hESCs with NIM, 
the number of neurites of total cells was 0.45, while the neurite number of cells with 
neurites was 1.90.  The gap between two values was 1.45.  Meanwhile, in group 
Ⅲ, neurally induced hESCs with NIM and the MNPs, the number of neurites was 
1.31 when total cells were calculated, whereas the neurite number was 1.54 when 
cells sprouting neurites were calculated.  The gap between the values was 0.23.  
Finally, in the last group (Ⅳ), neurally induced hEBs, the average number of neurites 
per cell of total cells was 1.94 and number of cells with neurites was 2.50.  The gap 
between two values was 0.56.  Compared to group Ⅲ and Ⅳ, the gap of Ⅱ was 
largest due to the biggest proportion of the cells without neurites.  According to 
Table 6.2, more than half of the cells (64.1%) did not possess any neurites in group 
Ⅱ, while about only 10% of the cells lack of neurites in Ⅲ and Ⅳ. 
Concerning the length of neurites per cell, I measured every single neurite of all 
the cells and calculated such values below.  First, the length of primary neurite was 
evaluated in all of the cells with neurites.  The mean value of the length in group Ⅱ 
was much shorter than in Ⅲ and Ⅳ.  Based on the number of neurites per cell 
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discussed above, it indicated that the length of primary neurites could be short when 
there was only a single neurite per cell, while the length of primary neurites would 
be longer when there were 2 or more neurites per cell.  Second, the length of sum 
of primary and secondary neurites was estimated when there were 2 or more neurites 
per cell.  The tendency among 3 groups was similar to the length of primary 
neurites.  Sum of primary and secondary neurites increased from group Ⅱ to Ⅳ.  
Third, the length of total neurites was measured in all of the cells sprouting neurites.  
Likewise, the length increased toward end group (Ⅳ). 
Additionally, I compared the difference in the length of total neurites and the 
length of primary neurites among the experimental groups.  The difference between 
the two lengths represents the length of sum of neurites except for primary neurites.  
That is to say, the value indicates sum of secondary, third, and shorter neurites.  The 
subtract in group Ⅱ was 37.57 μm, in Ⅲ was 78.08 μm, and in Ⅳ was 92.24 μm, 
respectively.  The value was smallest in group Ⅱ.  Accordingly, in addition to the 
length of primary neurites, the length of shorter neurites was much longer in the 
group Ⅲ and Ⅳ compared with Ⅱ.  Thus, it implies that as the number of neurites 
per cell increases, the length of each neurite enhances, either. 
In genetical analysis of the hESCs for detecting neural induction, I investigated 
representative neural induction marker genes such as growth associated protein 
43(GAP43), β3-tubulin (TUBB3), nestin (NES) and glial fibrillary acidic protein 
(GFAP).  However, only TUBB3 showed different tendency in expression contrary 
to the other genes.  All the neural induction markers except for TUBB3 were 
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statistically up-regulated in the experimental group Ⅲ and Ⅳ compared with Ⅰ and 
Ⅱ.  Especially, in group Ⅳ, the expression of each gene was enhanced than Ⅲ.  
But TUBB3 expression in Ⅳ decreased compared to group Ⅱ and Ⅲ.  Based on the 
fact that the role of TUBB3 is related to microtubule formation [180-182], the 3D 
culture condition, in which cells were cultivated in the suspended condition, may 
have a negative effect on producing microtubules, as compared with the two-
dimensional (2D) culture condition, in which the cells adhere to the bottom and 
generate cytoskeletons as well. 
In chapter 7, the mechanisms of accelerated neural induction of the small-sized 
hEBs were investigated.  First, WNT signaling pathway was analyzed in 4 
experimental groups.  The WNT5α and WNT3 were expressed in group Ⅱ and Ⅳ, 
respectively.  Though both WNT proteins are known to be involved in neural 
induction of the pluripotent stem cells (PSCs) into neural progenitor cells (NPCs) 
[134-139], exact function of each protein is different.  According to the related 
studies, the activation of WNT3 results in not only induction of the PSCs into NPCs, 
but also differentiation of the NPCs into mature neurons [134-136], whereas the 
WNT5α mediates the differentiation of NPCs into both neurons and glial cells [137-
139].  Therefore, the experimental group Ⅳ, in which the WNT3 protein expressed 
remarkably, was induced to neuronal direction following WNT3 signaling pathway, 
while the group Ⅱ was differentiated following WNT5α signaling pathway.  
According to the genetical analysis of the 4 experimental groups in chapter 6.5, the 
expression of GFAP was enhanced in group Ⅳ compared with other groups.  
Regarding that GFAP indicates the glial fibrillary acidic protein, improved GFAP 
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expression in group Ⅳ would be considered as the differentiation of hESCs into glial 
cells.  However, through the WNT3 expression in the experimental group Ⅳ, it was 
evaluated that the hESCs in Ⅳ were induced to neuronal direction.  Thus, it could 
be inferred that increased GFAP expression in group Ⅳ would be related to 
intermediate filament growth, which is one of the important roles of GFAP gene, and 
the hESCs in group Ⅳ were neurally induced through WNT3 signaling pathway 
[183-185].  Regarding group Ⅲ, both WNT3 and WNT5α did not show any 
expression.  The signaling pathway related to Ⅲ should be revealed. 
Since the cell culture condition was different as 2D and 3D, depending on the 
experimental groups, the expression of the related proteins affected by this physical 
environment was investigated in neurally induced hESCs (group Ⅱ to Ⅳ).  The 
expression of neural cell adhesion molecule (NCAM), microtubule-associated 
protein 2 (MAP2), and focal adhesion kinase (FAK) has been considered to be 
suppressed in 3D suspended cell culture condition.  However, according to the 
results, there was no statistical difference in the expression of NCAM, MAP2, and 
FAK between adhesive cells, cultured in 2D condition, and suspended cells, cultured 
in 3D condition.  Consequently, it indicates that cell-to-cell adhesions and 
interactions were improved in the hESCs differentiated in 3D suspended condition 
(Ⅳ), in which cell adhesion to bottom was inhibited.  Accordingly, by these 
enhanced intercellular communications, growth of cytoskeletons was sufficient in 
the suspended cells (Ⅳ) and the neurally induced hESCs of Ⅳ underwent focal 
adhesive stimulations, like cells in 2D (Ⅱ and Ⅲ) did.  It is considered to result from 
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a particular cell culture condition of the group Ⅳ, in which magnetic driven force 
was applied under the concentrated magnetic force system. 
According to the genetical analysis of the 4 experimental groups in chapter 6.5, 
the expression of TUBB3 decreased in group Ⅳ compared with group Ⅱ and Ⅲ.  
Regarding that TUBB3 gene expresses microtubules, down regulated TUBB3 
expression in group Ⅳ would be considered as failure of cytoskeleton formation.  
However, according to the MAP2 expression in the experimental group Ⅳ, it was 
verified that the hESCs in Ⅳ generated and organized sufficient cytoskeletons such 
as microtubules, like the hESCs in the group Ⅱ and Ⅲ did.  Thus, it could be 
inferred that decreased TUBB3 is one of the genes regulate the growth and genesis 
of microtubules, and the final complexed cytoskeletons would be produced by the 
interaction of various related genes [186-188].  Therefore, though TUBB3 gene 
expression in group Ⅳ was suppressed compared with other groups, practical 
generation of cytoskeletons represented as microtubules in group Ⅳ was not 
significantly different when comparing with the group Ⅱ and Ⅲ. 
In this thesis, the key issue is to identify the critical difference that directs the fate 
of the hESCs between small and large hEBs.  The physically defined difference in 
the hEB size is associated with a restriction in the area of mass transfer.  As the size 
of the hEBs increases, the region of restricted mass transfer would increase from the 
core, and indeed core part underwent cell death in the large hEBs, resulting in the 
formation of a large lumen.  Because the cavitation that occurs through central 
apoptosis has been regarded as a significant cue for embryological process [189, 
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190], the difference in the scale and moment of the cavitation would induce separate 
mechanisms sequentially, resulting in distinct lineage specification.  However, it is 
still unclear how the hESC clusters recognize their size and which mechanisms are 
engaged as a result.  In the case of bacteria, they coordinate certain behaviors in 
response to their local cell density using innate cell-to-cell communication, called 
quorum sensing [191, 192].  As such, it is necessary to investigate the change in 
intercellular communication and subsequent signaling of the hESCs in various forms.  
Also, further studies are needed to elucidate the underlying biology of the hESC 
behavior depending on the hEB size and related factors to better understand the 
direction of the hESC fate. 
In spontaneous differentiation of the hESCs in the form of hEBs, generated using 
the MNPs and the concentrated magnetic force system, the MNPs themselves did 
not have significant effect on directing the hESC fate.  According to related studies, 
the MNPs did not influence on specific differentiation of PSCs [193, 194].  
However, when the MNPs were applied to particular progenitor cells with 
differentiation condition, such as differentiation medium with growth factors, it 
seemed that the MNPs induce or help some differentiation.  In this research, 
according to the comparison of neural induction through ICC and genetical analysis, 
the group Ⅲ showed statistically enhanced neural inductivity when compared with Ⅰ 
and Ⅱ.  Though the MNPs themselves do not regulate the differentiation of hESCs, 
the MNPs could synergically affect specific differentiation when treated with 
chemical inducers, as in NIM.  In previous works, the behavior and change of 
intracellularly delivered MNPs have been discussed [84, 86, 171].  The 
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endocytosed MNPs would be ionized producing iron ion in intracellular organelles, 
in which pH is low and the environment is acidic.  And this iron ion could affect 
particular cell commitments in various ways.  The detailed mechanisms related to 
the synergic effect of the MNPs on neural induction should be revealed and thus the 
exact role and function of the MNPs on neural induction of the hESCs have to be 
established. 
Through the analysis of several signaling pathways, I tried to find the cause of 
accelerated neural induction of small-sized hEBs compared with conventionally 
differentiated hESCs.  As a result, the improved neural induction of the hEBs 
followed WNT3 signaling pathways and possessed dopamine affinity.  
Furthermore, enhanced cell-to-cell interactions resulted from magnetic force-derived 
mechanical stimuli affected the results.  Although I compared two groups in the 
expression of those signaling pathway proteins, in order to clarify the related 
mechanisms, it is considered that numerous proteins should be investigated 
according to significant cascades. 
To summarize, in my research during Ph.D., I have devised a technique to 
efficiently generate hEBs and regulate their sizes using MNPs and the concentrated 
magnetic force system.  Through the method, I could reveal the effect of hEB size 
on the hESC fate.  In addition, I successfully improved neural induction of the 
hESCs by generating small-sized hEBs, and also reduced the time required for early 
neural induction.  Furthermore, I confirmed the related signaling pathways 
affecting the accelerated neural induction of the hESCs.  Therefore, the MNP-based 
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hEB size control method proposed in this study would be useful for inducing lineage-
specific differentiation of hESCs and determining the cell fate.  If this technique 
could be used to induce the differentiation of hESCs into various cell types, 
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인간배아체의 크기 조절 구현 및 
이를 통한 인간배아줄기세포의 분화 조절 
 





인간배아줄기세포(human embryonic stem cells, hESCs)는 자가재생력(self-
renewal) 및 분화능(differentiation)이라고 하는 고유한 특성을 가지는 세포
로서, 이와 같은 성질로 인해 조직공학(tissue engineering)과 재생의학
(regenerative medicine) 분야에서 유망한 재료로 널리 사용되어왔다.  아울
러, 인간배아줄기세포를 3차원의 형태인 인간배아체(human embryoid 
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bodies, hEBs)로 구현하여 분화를 유도하는 것은 실제로 체내에서 일어나
는 배아의 발생 과정(embryogenesis)과 상당부분 유사점을 가지고 있다. 
이 때문에, 인간배아체는 인간의 배아 발생 과정에 대한 이해 및 통찰을 
돕는 데 적합한 도구로서 이용되고 있다. 
본 연구에서는 먼저, 세포 투과성(cell-penetrating) 자성나노입자
(magnetic nanoparticles, MNPs)를 이용하여 인간배아체를 정해진 크기로 제
작하였다.  그리고 이렇게 구현된 인간배아체의 분화 양상을 분석하였다.  
그 과정에서 충분한 양의 자성나노입자를 인간배아줄기세포 안쪽으로 도
입하기 위해, 피더(feeder)라고 하는 도움 세포와 함께 배양되던 인간배아
줄기세포를 피더가 없는 환경에서 배양하도록 개선하였다.  그리고 자성
나노입자의 도입에 의해 자화 된(magnetized) 인간배아줄기세포를 부유 
시켜, 자성 핀(pin) 기반의 집중된 자기력 시스템(concentrated magnetic 
force system)에 넣어 줌으로써 효과적으로 인간배아체로 뭉치도록 유도하
였다.  이 때, 집중된 자기력 시스템의 한 개의 웰(well)에 넣어주는 세포
의 개수를 조절함으로써 제작하는 인간배아체의 크기를 조절할 수 있었
다.  인간배아체를 부유하는 상태로 3일간 배양한 결과, 크기가 작은 인
간배아체(지름 150 μm)에서는 외배엽성 분화(ectodermal differentiation)가 
증진되고, 크기가 큰 인간배아체(지름 600 μm)에서는 내배엽 및 중배엽성 
분화(endodermal and mesodermal differentiation)가 증진된 것을 확인하였다. 
크기가 조절된 인간배아체가 자발적으로 분화되도록 유도하는 과정에
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서, 작은 크기의 인간배아체 중 신경교섬유질산성단백질(glial fibrillary 
acidic protein, GFAP) 염색에서 양성을 띄었던 일부 세포가 신경 돌기
(neurites)를 뻗어내는 것과 같은 양상을 보였다.  실제로 많은 연구자들
이 인간배아체를 가지고 신경 분화를 시키고자 연구해오고 있는데, 그 
이유는 인간배아체의 탄성(elasticity)이 뇌의 조직 탄성과 비슷하고, 나아
가 인간배아체에서 증진되는 세포 간 상호작용력이 실제 신경세포의 그
것과 유사하기 때문이다.  이 연구에서는 앞서 제작한 작은 크기의 인간
배아체를 보다 증진된 방향으로 신경 분화 시키기 위해서 신경유도배지
(neural induction medium, NIM)를 5일간 사용하였다(Ⅳ).  그리고 다른 3개
의 대조실험군을 설정하여 신경 분화의 증진 정도를 비교하였다; 분화시
키지 않아서 분화능을 유지하고 있는 인간배아줄기세포(Ⅰ), 신경유도배지
를 이용해 5일간 분화시킨 인간배아줄기세포(Ⅱ) 그리고 신경유도배지와 
자성나노입자를 사용해 5일간 분화 유도한 인간배아줄기세포(Ⅲ).  다른 
실험군과 비교하여 신경 분화를 유도한 작은 크기의 인간배아체에서 통
계적으로 유의미한 신경 유도의 증진 현상이 관찰되었다.  더불어, 자성
나노입자가 신경유도배지와 함께 쓰였을 때, 신경 유도를 증진하는 효과
가 있는 것으로 드러났다.  그리고 Ⅳ에서 증진된 신경 유도를 설명하는 
신호 기전을 확인하고자 몇몇 단백질의 발현 여부를 추가적으로 확인하
였다. 대표적인 단백질로는, 윈트(WNT) 단백질, 도파민반응성 신경 관련 
단백질, 세포 간 상호작용과 관련된 단백질 그리고 메카노트랜스덕션
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(mechanotransduction) 관련 단백질이 있다.  
종합하자면, 필자는 본 연구에서 자성나노입자를 이용해 인간배아체를 
효과적으로 구현하고 그것의 크기를 자유자재로 조절하는 기술을 고안하
였다.  그리고 이 기술을 이용하여 인간배아줄기세포의 초기 분화 방향
을 결정하는 중요한 요소 가운데 하나로서 인간배아체의 크기가 있다는 
사실을 확인 할 수 있었다.  나아가, 크기가 작은 인간배아체를 구현하여 
신경 유도를 시키는 연구로 심화하였는데, 신경 분화가 효과적으로 증진
되어 결과적으로는 초기 신경 유도에 걸리는 시간을 대폭 단축할 수 있
었다. 그리고 이 과정이 윈트(WNT) 신호전달체계 및 도파민성 신경신호
전달체계를 따른다는 것을 확인할 수 있었다.  나아가, 이 같은 결과가 
자성나노입자 기반의 인간배아체 구현 기술에서 기인하는 세포 간 상호
작용력 증진 및 메카노트랜스덕션(mechanotransduction)에 의한 것임을 알 
수 있었다.  따라서 본 연구에서 제안한 자성나노입자를 이용해 인간배
아체의 크기를 조절하는 방법은 인간배아줄기세포의 특성화된 분화
(lineage-specific differentiation) 유도 및 그를 통한 세포의 운명(fate) 결정
에 매우 유용하고 가치 있는 기술이라고 할 수 있다.  이 기술을 이용해 
인간배아줄기세포를 보다 다양한 종류의 세포로 분화 유도 할 수 있다면, 
조직공학적 응용이 가능할 것이며 나아가 인간 배아의 발생과정을 모사
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